BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;220:364-372; discussion 372-373. [PMID: 8092902 DOI: 10.1097/00000658-199409000-00012] [Cited by in Crossref: 656] [Cited by in F6Publishing: 550] [Article Influence: 23.4] [Reference Citation Analysis]
Number Citing Articles
1 Koide N, Hiraguri M, Nishio A, Igarashi J, Watanabe H, Adachi W, Amano J. Three Elderly Patients With Lower Esophageal Cancer Successfully Treated By Transhiatal Esophagectomy Assisted by Mediastinoscopy: . Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2000;10:391-5. [DOI: 10.1097/00129689-200012000-00011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
2 Nigro JJ, Hagen JA, Demeester TR, Demeester SR, Peters JH, Öberg S, Theisen J, Kiyabu M, Crookes PF, Bremner CG. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy. The Journal of Thoracic and Cardiovascular Surgery 1999;117:16-25. [DOI: 10.1016/s0022-5223(99)70464-2] [Cited by in Crossref: 142] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
3 Ellis F, Heatley GJ, Krasna M, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: A comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. The Journal of Thoracic and Cardiovascular Surgery 1997;113:836-48. [DOI: 10.1016/s0022-5223(97)70256-3] [Cited by in Crossref: 148] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
4 Hagens ERC, van Berge Henegouwen MI, Gisbertz SS. Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review. Cancers (Basel) 2020;12:E1592. [PMID: 32560226 DOI: 10.3390/cancers12061592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Jingu K, Nemoto K, Matsushita H, Takahashi C, Ogawa Y, Sugawara T, Nakata E, Takai Y, Yamada S. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer. 2006;6:50. [PMID: 16515704 DOI: 10.1186/1471-2407-6-50] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
6 Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M, Ishizaki K. Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy. Ann Surg 1997;226:162-8. [PMID: 9296509 DOI: 10.1097/00000658-199708000-00007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
7 Takeuchi H, Kitagawa Y. Sentinel node navigation surgery for esophageal cancer. Gen Thorac Cardiovasc Surg 2008;56:393-6. [DOI: 10.1007/s11748-008-0264-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
8 Owaki T, Matsumoto M, Okumura H, Uchicado Y, Kita Y, Setoyama T, Sasaki K, Sakurai T, Omoto I, Shimada M, Sakamoto F, Yoshinaka H, Ishigami S, Ueno S, Natsugoe S. Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma. The American Journal of Surgery 2012;203:191-7. [DOI: 10.1016/j.amjsurg.2011.01.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ohi M, Toiyama Y, Yasuda H, Ichikawa T, Imaoka H, Okugawa Y, Fujikawa H, Okita Y, Yokoe T, Hiro J, Kusunoki M. Preoperative computed tomography predicts the risk of recurrent laryngeal nerve paralysis in patients with esophageal cancer undergoing thoracoscopic esophagectomy in the prone position. Esophagus 2021;18:228-38. [PMID: 32743739 DOI: 10.1007/s10388-020-00767-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Isayama F, Matsumoto T, Tsurumaru M. Size analysis of lymph node metastasis in esophageal cancer: diameter distribution and assessment of accuracy of preoperative diagnosis. Esophagus 2006;3:189-95. [DOI: 10.1007/s10388-006-0092-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
11 Jingu K, Matsushita H, Takeda K, Umezawa R, Takahashi C, Sugawara T, Kubozono M, Abe K, Tanabe T, Shirata Y, Yamamoto T, Ishikawa Y, Nemoto K. Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study. BMC Cancer 2012;12:542. [PMID: 23171077 DOI: 10.1186/1471-2407-12-542] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
12 Sugahara S, Tokuuye K, Okumura T, Nakahara A, Saida Y, Kagei K, Ohara K, Hata M, Igaki H, Akine Y. Clinical results of proton beam therapy for cancer of the esophagus. International Journal of Radiation Oncology*Biology*Physics 2005;61:76-84. [DOI: 10.1016/j.ijrobp.2004.04.003] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
13 Saeki H, Sohda M, Sakai M, Sano A, Shirabe K. Role of surgery in multidisciplinary treatment strategies for locally advanced esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2020;4:490-7. [PMID: 33005843 DOI: 10.1002/ags3.12364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Law S, Kwong DL, Wong KH, Kwok KF, Wong J. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 2006;10:1301-11. [PMID: 17114016 DOI: 10.1016/j.gassur.2006.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
15 Noguchi T, Wada S, Takeno S, Hashimoto T, Moriyama H, Uchida Y. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma. Dis Esophagus. 2004;17:27-31. [PMID: 15209737 DOI: 10.1111/j.1442-2050.2004.00353.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
16 Dexter SP, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut. 2001;48:667-670. [PMID: 11302966 DOI: 10.1136/gut.48.5.667] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 5.4] [Reference Citation Analysis]
17 Park JO, Posner MC. Standard surgical approaches in the management of esophageal cancer. Surgical Oncology Clinics of North America 2002;11:351-63. [DOI: 10.1016/s1055-3207(02)00011-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Krasna MJ, Jiao X, Sonett JR, Gamliel Z, Eslami A, Raefaly Y, Mao Y. Thoracoscopic and laparoscopic lymph node staging in esophageal cancer: do clinicopathological factors affect the outcome. Ann Thorac Surg. 2002;73:1710-1713. [PMID: 12078757 DOI: 10.1016/s0003-4975(02)03552-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ulrich B, Zahedi A. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction. Dis Esophagus 2001;14:115-9. [PMID: 11553220 DOI: 10.1046/j.1442-2050.2001.00167.x] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
20 Chao Y, Wu Y, Liu Y, Tseng C, Chang H, Hsieh M, Chu Y, Liu H. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: Characteristics of long-term survivors after chemoradiotherapy. J Surg Oncol 2010;102:158-62. [DOI: 10.1002/jso.21588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
21 Mizukami Y, Kono K, Daigo Y, Takano A, Tsunoda T, Kawaguchi Y, Nakamura Y, Fujii H. Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma. Cancer Sci. 2008;99:1448-1454. [PMID: 18452554 DOI: 10.1111/j.1349-7006.2008.00844.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
22 Tachibana M, Yoshimura H, Kinugasa S, Ohar D, Shibakita M, Ohno S, Ueda S, Fujii T, Nagasue N. Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer. Digestive and Liver Disease 2001;33:534-8. [DOI: 10.1016/s1590-8658(01)80103-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
23 Igaki H, Kato H, Tachimori Y, Nakanishi Y, Shimoda T. Surgery for clinical T3 carcinomas of the upper thoracic oesophagus and the need for new strategies. British Journal of Surgery 2005;92:1235-40. [DOI: 10.1002/bjs.5081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Yamada H, Hosokawa M, Itoh K, Takenouchi T, Kinoshita Y, Kikkawa T, Sakashita K, Uemura S, Nishida Y, Kusumi T. Diagnostic value of 18F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma. Surg Today. 2014;44:1258-1265. [PMID: 24077997 DOI: 10.1007/s00595-013-0725-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
25 Sakai N, Kajiyama Y, Iwanuma Y, Tomita N, Amano T, Isayama F, Ouchi K, Tsurumaru M. Study of abnormal chromosome regions in esophageal squamous cell carcinoma by comparative genomic hybridization: relationship of lymph node metastasis and distant metastasis to selected abnormal regions. Dis Esophagus 2010;23:415-21. [PMID: 19930403 DOI: 10.1111/j.1442-2050.2009.01026.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 0.2] [Reference Citation Analysis]
26 Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83. [PMID: 12170022 DOI: 10.1097/00000658-200208000-00005] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Vrouenraets BC, van Lanschot JJB. Extent of Surgical Resection for Esophageal and Gastroesophageal Junction Adenocarcinomas. Surgical Oncology Clinics of North America 2006;15:781-91. [DOI: 10.1016/j.soc.2006.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
28 Yano M, Sugimura K, Miyata H, Motoori M, Tanaka K, Omori T, Ohue M, Sakon M. Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After Esophagectomy. Ann Surg 2020;272:48-54. [PMID: 31415003 DOI: 10.1097/SLA.0000000000003557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Seike J, Sawada T, Kawakita N, Yamamoto Y, Yuasa Y, Yamai H, Takachi H, Yoshida T, Tangoku A. A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP. Int J Surg Oncol 2011;2011:715623. [PMID: 22312520 DOI: 10.1155/2011/715623] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
30 Zhang SS, Yang H, Xie X, Luo KJ, Wen J, Bella AE, Hu Y, Yang F, Fu JH. Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Dis Esophagus. 2014;27:574-584. [PMID: 23621119 DOI: 10.1111/dote.12073] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
31 Moreno MCF, Law S. Surgical Protocols for Squamous Cell Cancer of the Esophagus. Methods Mol Biol 2020;2129:335-58. [PMID: 32056189 DOI: 10.1007/978-1-0716-0377-2_25] [Reference Citation Analysis]
32 Kato H, Fukuchi M, Miyazaki T, Nakajima M, Tanaka N, Inose T, Kimura H, Faried A, Saito K, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Kuwano H. Surgical treatment for esophageal cancer. Current issues. Dig Surg 2007;24:88-95. [PMID: 17446703 DOI: 10.1159/000101894] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
33 Stockeld D, Backman L, Fagerberg J, Granström L. Esophageal cancer in Stockholm county 1978–1995. Acta Oncologica 2009;46:1075-84. [DOI: 10.1080/02841860701426807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
34 Kushida T, Nohara S, Yoshino K, Fujiwara D, Ouchi K, Amano T, Isayama F, Tomita N, Iwanuma Y, Sasai K, Tsurumaru M, Kajiyama Y. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis: Chemoradiotherapy for esophageal cancer. Dis Esophagus 2014;27:368-73. [DOI: 10.1111/dote.12105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
35 Miyata H, Doki Y, Yasuda T, Yamasaki M, Higuchi I, Makari Y, Matsuyama J, Hirao T, Takiguchi S, Fujiwara Y, Monden M. Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus. Dis Esophagus. 2008;21:144-150. [PMID: 18269650 DOI: 10.1111/j.1442-2050.2007.00743.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
36 Oshikiri T, Yasuda T, Kawasaki K, Harada H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. Hand-assisted laparoscopic surgery (HALS) is associated with less-restrictive ventilatory impairment and less risk for pulmonary complication than open laparotomy in thoracoscopic esophagectomy. Surgery. 2016;159:459-466. [PMID: 26361833 DOI: 10.1016/j.surg.2015.07.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
37 Lerut T, Wiesel O. History of esophagectomy for cancer of the esophagus and the gastroesophageal junction. Ann Transl Med 2021;9:897. [PMID: 34164531 DOI: 10.21037/atm-21-676] [Reference Citation Analysis]
38 Chen J, Wu S, Zheng X, Pan J, Zhu K, Chen Y, Li J, Liao L, Lin Y, Liao Z. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection. BMC Surg 2014;14:110. [PMID: 25527100 DOI: 10.1186/1471-2482-14-110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
39 Suttie SA, Li AG, Quinn M, Park KG. The impact of operative approach on outcome of surgery for gastro-oesophageal tumours. World J Surg Oncol 2007;5:95. [PMID: 17708773 DOI: 10.1186/1477-7819-5-95] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Lerut T. Esophageal surgery at the end of the millennium. The Journal of Thoracic and Cardiovascular Surgery 1998;116:1-20. [DOI: 10.1016/s0022-5223(98)70237-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
41 Moaven O, Wang TN. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West. Surg Clin North Am 2019;99:479-99. [PMID: 31047037 DOI: 10.1016/j.suc.2019.02.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Urschel JD, Ashiku S, Thurer R, Sellke FW. Salvage or planned esophagectomy after chemoradiation therapy for locally advanced esophageal cancer – a review. Diseases of the Esophagus 2003;16:60-5. [DOI: 10.1046/j.1442-2050.2003.00296.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.9] [Reference Citation Analysis]
43 Tabira Y, Yasunaga M, Sakaguchi T, Yamaguchi Y, Okuma T, Kawasuji M. Outcome of histologically node-negative esophageal squamous cell carcinoma. World J Surg 2002;26:1446-51. [PMID: 12297913 DOI: 10.1007/s00268-002-6415-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
44 Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Imaoka S. Preoperative chemotherapy for clinically node-positive patients with squamous cell carcinoma of the esophagus. Diseases of the Esophagus 2006;19:158-63. [DOI: 10.1111/j.1442-2050.2006.00558.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
45 Clark G, Roy M, Corcoran B, Carey P. Carcinoma of the oesophagus: The time for a multidiciplinary approach? Surgical Oncology 1996;5:149-64. [DOI: 10.1016/s0960-7404(96)80038-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 van de Ven C, De Leyn P, Coosemans W, Van Raemdonck D, Lerut T. Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. Eur J Cardiothorac Surg 1999;15:769-73. [PMID: 10431857 DOI: 10.1016/s1010-7940(99)00122-0] [Cited by in Crossref: 58] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
47 Matsumoto S, Takayama T, Tamamoto T, Wakatsuki K, Enomoto K, Tanaka T, Migita K, Asakawa I, Hasegawa M, Nakajima Y. A comparison of surgery and radiation therapy for cT1 esophageal squamous cell carcinoma. Dis Esophagus 2011;24:411-7. [PMID: 21309913 DOI: 10.1111/j.1442-2050.2010.01163.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
48 Sakurai Y, Kanaya S, Komori Y, Uyama I. Is postoperative early enteral nutrition with regular or disease-specific enteral formula really beneficial in patients undergoing esophagectomy? Esophagus 2009;6:149-54. [DOI: 10.1007/s10388-009-0196-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Kosugi S, Kanda T, Yajima K, Ishikawa T, Hatakeyama K. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection. Ann Surg Oncol 2011;18:2961-7. [PMID: 21499809 DOI: 10.1245/s10434-011-1712-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
50 Lin J, Kang M, Chen C, Lin R, Zheng W, Zhug Y, Deng F, Chen S. Thoracolaparoscopy oesophagectomy and extensive two-field lymphadenectomy for oesophageal cancer: introduction and teaching of a new technique in a high-volume centre. Eur J Cardiothorac Surg. 2013;43:115-121. [PMID: 22518035 DOI: 10.1093/ejcts/ezs151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
51 Watanabe M, Mine S, Yamada K, Shigaki H, Baba Y, Yoshida N, Kajiyama K, Yamamoto N, Sano T, Baba H. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg 2014;62:685-92. [PMID: 24965711 DOI: 10.1007/s11748-014-0444-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
52 Law S, Wong J. Therapeutic options for esophageal cancer. J Gastroenterol Hepatol 2004;19:4-12. [PMID: 14675236 DOI: 10.1111/j.1440-1746.2004.03154.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
53 Mariette C, Piessen G. Oesophageal cancer: how radical should surgery be? Eur J Surg Oncol 2012;38:210-3. [PMID: 22236956 DOI: 10.1016/j.ejso.2011.12.022] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
54 Chen J, Cai W, Zheng X, Chen Y, Lin Y, Chen X, Zhu K, Chen C. The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy. Radiotherapy and Oncology 2017;123:382-6. [DOI: 10.1016/j.radonc.2017.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
55 Ninomiya I, Okamoto K, Tsukada T, Kinoshita J, Oyama K, Fushida S, Osugi H, Ohta T. Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma. Mol Clin Oncol. 2016;4:278-284. [PMID: 26893875 DOI: 10.3892/mco.2015.688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
56 Chen X, Chen J, Zheng X, Chen Y, Lin Y, Zheng Q, Zhu K, Pan J. Prognostic factors in patients with thoracic esophageal carcinoma staged pT1-4aN0M0 undergone esophagectomy with three-field lymphadenectomy. Ann Transl Med 2015;3:282. [PMID: 26697442 DOI: 10.3978/j.issn.2305-5839.2015.11.05] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Li BS, Gong HY, Huang W, Yi Y, Zhang ZC, Li HS, Wang ZT, Yu JM. Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and pemetrexed, cisplatin for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2011;24:251-7. [PMID: 21073623 DOI: 10.1111/j.1442-2050.2010.01130.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
58 Hayashi H, Tangoku A, Suga K, Shimizu K, Ueda K, Yoshino S, Abe T, Sato T, Matsunaga N, Oka M. CT lymphography-navigated sentinel lymph node biopsy in patients with superficial esophageal cancer. Surgery 2006;139:224-35. [DOI: 10.1016/j.surg.2005.07.027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
59 Blazeby JM, Alderson D. Review: Chemotherapy, irradiation and their roles in the management of oesophageal cancer. J Gastroenterol Hepatol 1997;12:612-9. [DOI: 10.1111/j.1440-1746.1997.tb00494.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Altorki N. Two-field lymph node dissection or three-field lymph node dissection. What's in a name? J Thorac Cardiovasc Surg 2021:S0022-5223(21)01040-0. [PMID: 34321179 DOI: 10.1016/j.jtcvs.2021.06.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Lv B, Tao YZ, Zhu Y, Wu J, Zhong B, Luo FC, Liu Y, Zhang ZX. Comparison of the outcomes between thoracoscopic and laparoscopic esophagectomy via retrosternal and prevertebral lifting paths by the same surgeon. World J Surg Oncol 2017;15:166. [PMID: 28854945 DOI: 10.1186/s12957-017-1219-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Kanemura T, Makino T, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. Distribution patterns of metastases in recurrent laryngeal nerve lymph nodes in patients with squamous cell esophageal cancer. Dis Esophagus 2017;30:1-7. [PMID: 27630087 DOI: 10.1111/dote.12527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
63 Nakajima M, Muroi H, Yokoyama H, Kikuchi M, Yamaguchi S, Sasaki K, Kato H. 18 F-Fluorodeoxyglucose positron emission tomography can be used to determine the indication for endoscopic resection of superficial esophageal cancer. Cancer Med. 2018;7:3604-3610. [PMID: 29953743 DOI: 10.1002/cam4.1628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
64 Chan AC, Lee DW, Griffith JF, Leung SF, Lam YH, Lam CC, Lau JY, Ng EK, Chung SC. The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: a prospective nonrandomized study of pulse and continuous-infusion regimens with Cisplatin and 5-Fluorouracil. Ann Surg Oncol 2002;9:617-24. [PMID: 12167574 DOI: 10.1007/BF02574476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
65 Yoshioka S, Fujiwara Y, Sugita Y, Okada Y, Yano M, Tamura S, Yasuda T, Takiguchi S, Shiozaki H, Monden M. Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers. Surgery. 2002;132:34-40. [PMID: 12110793 DOI: 10.1067/msy.2002.125306] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
66 Siewert JR, Stein HJ, Lordick F. Ösophaguskarzinom. In: Siewert JR, Rothmund M, Schumpelick V, editors. Praxis der Viszeralchirurgie. Berlin/Heidelberg: Springer-Verlag; 2006. pp. 403-33. [DOI: 10.1007/3-540-30036-8_35] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
67 Kinugasa S, Tachibana M, Yoshimura H, Dhar DK, Shibakita M, Ohno S, Kubota H, Masunaga R, Nagasue N. Esophageal resection in elderly esophageal carcinoma patients: improvement in postoperative complications. Ann Thorac Surg. 2001;71:414-418. [PMID: 11235680 DOI: 10.1016/s0003-4975(00)02333-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
68 Shu Y, Miao Q, Shi W, Shi H, Lu S, Wang K. Evaluation of three-incision esophagectomy: Review of 1226 patients. Chin -Ger J Clin Oncol 2010;9:507-10. [DOI: 10.1007/s10330-010-0663-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Tan Z, Ma G, Zhao J, Bella AE, Rong T, Fu J, Meng Y, Luo K, Situ D, Lin P. Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy. J Gastrointest Surg. 2014;18:187-193. [PMID: 24241966 DOI: 10.1007/s11605-013-2411-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
70 Noshiro H, Iwasaki H, Kobayashi K, Uchiyama A, Miyasaka Y, Masatsugu T, Koike K, Miyazaki K. Lymphadenectomy along the left recurrent laryngeal nerve by a minimally invasive esophagectomy in the prone position for thoracic esophageal cancer. Surg Endosc. 2010;24:2965-2973. [PMID: 20495981 DOI: 10.1007/s00464-010-1072-4] [Cited by in Crossref: 116] [Cited by in F6Publishing: 101] [Article Influence: 9.7] [Reference Citation Analysis]
71 Law S, Wong J. The current management of esophageal cancer. Adv Surg 2007;41:93-119. [PMID: 17972559 DOI: 10.1016/j.yasu.2007.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
72 Maruyama T, Kono K, Izawa S, Mizukami Y, Kawaguchi Y, Mimura K, Watanabe M, Fujii H. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma. Dis Esophagus 2010;23:422-9. [PMID: 20002703 DOI: 10.1111/j.1442-2050.2009.01029.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 32] [Article Influence: 0.9] [Reference Citation Analysis]
73 Lerut T, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Multidisciplinary treatment of advanced cancer of the esophagus and gastroesophageal junction: a European center's approach. Surg Oncol Clin N Am 2008;17:485-502, vii-viii. [PMID: 18486879 DOI: 10.1016/j.soc.2008.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
74 Atsumi K, Shioyama Y, Nakamura K, Nomoto S, Ohga S, Yoshitake T, Nonoshita T, Ueda M, Hirata H, Honda H. Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer. J Radiat Res. 2010;51:9-14. [PMID: 19801888 DOI: 10.1269/jrr.09073] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
75 Palanivelu C, Prakash A, Senthilkumar R, Senthilnathan P, Parthasarathi R, Rajan PS, Venkatachlam S. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position--experience of 130 patients. J Am Coll Surg. 2006;203:7-16. [PMID: 16798482 DOI: 10.1016/j.jamcollsurg.2006.03.016] [Cited by in Crossref: 295] [Cited by in F6Publishing: 247] [Article Influence: 18.4] [Reference Citation Analysis]
76 Fang W, Kato H, Tachimori Y, Igaki H, Sato H, Daiko H. Analysis of pulmonary complications after three-field lymph node dissection for esophageal cancer. Ann Thorac Surg. 2003;76:903-908. [PMID: 12963226 DOI: 10.1016/s0003-4975(03)00549-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
77 Shah SV, Chheda YP, Pillai SK, Shah SV. Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study. Indian J Surg Oncol 2013;4:336-40. [PMID: 24426753 DOI: 10.1007/s13193-013-0264-5] [Reference Citation Analysis]
78 Zhong D, Zhou Y, Li Y, Wang Y, Zhou W, Cheng Q, Chen L, Zhao J, Li X, Yan X. Intraoperative recurrent laryngeal nerve monitoring: a useful method for patients with esophageal cancer: RLNM for esophageal cancer. Dis Esophagus 2014;27:444-51. [DOI: 10.1111/j.1442-2050.2012.01414.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
79 Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 2019;19:662. [PMID: 31272485 DOI: 10.1186/s12885-019-5761-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
80 Tanaka K, Yamasaki M, Makino T, Yamashita K, Saitoh T, Takahashi T, Kurokawa Y, Nakajima K, Motoori M, Kimura Y, Mano M, Mori M, Eguchi H, Doki Y. Analysis of prognostic factors in patients with lymph node recurrence after radical esophagectomy: importance of locoregional therapy. Esophagus 2021;18:195-202. [PMID: 32875459 DOI: 10.1007/s10388-020-00778-x] [Reference Citation Analysis]
81 Motoori M, Yano M, Yasuda T, Miyata H, Peng YF, Yamasaki M, Shiraishi O, Tanaka K, Ishikawa O, Shiozaki H. Relationship between immunological parameters and the severity of neutropenia and effect of enteral nutrition on immune status during neoadjuvant chemotherapy on patients with advanced esophageal cancer. Oncology. 2012;83:91-100. [PMID: 22777298 DOI: 10.1159/000339694] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
82 Yau KK, Siu WT, Cheung HYS, Li ACN, Yang GPC, Li MKW. Immediate preoperative laparoscopic staging for squamous cell carcinoma of the esophagus. Surg Endosc 2006;20:307-10. [DOI: 10.1007/s00464-005-0336-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
83 Takeuchi H, Miyata H, Ozawa S, Udagawa H, Osugi H, Matsubara H, Konno H, Seto Y, Kitagawa Y. Comparison of Short-Term Outcomes Between Open and Minimally Invasive Esophagectomy for Esophageal Cancer Using a Nationwide Database in Japan. Ann Surg Oncol 2017;24:1821-7. [DOI: 10.1245/s10434-017-5808-4] [Cited by in Crossref: 101] [Cited by in F6Publishing: 91] [Article Influence: 20.2] [Reference Citation Analysis]
84 Chen G, Wang Z, Liu XY, Liu FY. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg. 2007;31:1107-1114. [PMID: 17426905 DOI: 10.1007/s00268-006-0551-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
85 Ueda Y, Shiozaki A, Itoi H, Okamoto K, Fujiwara H, Ichikawa D, Kikuchi S, Fuji N, Itoh T, Ochiai T, Yamagishi H. The Range of Tumor Extension Should Have Precedence over the Location of the Deepest Tumor Center in Determining the Regional Lymph Node Grouping for Widely Extending Esophageal Carcinomas. Japanese Journal of Clinical Oncology 2006;36:775-82. [DOI: 10.1093/jjco/hyl105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Jamieson GG, Lamb PJ, Thompson SK. The role of lymphadenectomy in esophageal cancer. Ann Surg. 2009;250:206-209. [PMID: 19638911 DOI: 10.1097/sla.0b013e3181b16cd1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
87 Lerut T, Coosemans W, Decker G, De Leyn P, Ectors N, Fieuws S, Moons J, Nafteux P, Van Raemdonck D. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg. 2003;126:1121-1128. [PMID: 14566257 DOI: 10.1016/s0022-5223(03)00941-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
88 Allum WH, Griffin SM, Watson A, Colin-Jones D; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland., British Society of Gastroenterology., British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2002;50 Suppl 5:v1-23. [PMID: 12049068 DOI: 10.1136/gut.50.90005.v1] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
89 Castoro C, Scarpa M, Cagol M, Ruol A, Cavallin F, Alfieri R, Zanchettin G, Rugge M, Ancona E. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol. 2011;18:3743-3754. [PMID: 21556952 DOI: 10.1245/s10434-011-1753-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
90 Law S, Wong J. Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103. [PMID: 11553217 DOI: 10.1046/j.1442-2050.2001.00164.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
91 Law S, Wong J. Use of minimally invasive oesophagectomy for cancer of the oesophagus. Lancet Oncol 2002;3:215-22. [PMID: 12067683 DOI: 10.1016/s1470-2045(02)00712-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
92 Yano M, Motoori M, Tanaka K, Kishi K, Fujiwara Y, Shingai T, Gotoh K, Takahashi H, Noura S, Yamada T, Ohue M, Ohigashi H, Ishikawa O. Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT). Esophagus 2012;9:210-6. [DOI: 10.1007/s10388-012-0342-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
93 Shimada H, Okazumi S, Matsubara H, Nabeya Y, Shiratori T, Shimizu T, Shuto K, Hayashi H, Ochiai T. Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 2006;30:1441-9. [PMID: 16871357 DOI: 10.1007/s00268-005-0462-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 4.7] [Reference Citation Analysis]
94 Gronnier C, Mariette C. [Lymph node involvement in œsophageal cancer: surgical approach]. Cancer Radiother 2014;18:559-64. [PMID: 25195112 DOI: 10.1016/j.canrad.2014.06.022] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
95 Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384. [PMID: 21651355 DOI: 10.1586/egh.11.33] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
96 Funai T, Osugi H, Higashino M, Kinoshita H. Estimation of lymph node metastasis by size in patients with intrathoracic oesophageal cancer. Br J Surg 2000;87:1234-9. [PMID: 10971434 DOI: 10.1046/j.1365-2168.2000.01527.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
97 Chen Y, Lee M, Chen P. Diagnosis and treatment of superficial oesophageal carcinoma. J Gastroenterol Hepatol 1997;12:778-84. [DOI: 10.1111/j.1440-1746.1997.tb00371.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
98 Hagen JA, Demeester TR. Esophageal adenocarcinoma. The Annals of Thoracic Surgery 2001;72:1430-2. [DOI: 10.1016/s0003-4975(01)02845-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
99 Yamashita H, Okuma K, Wakui R, Kobayashi-Shibata S, Ohtomo K, Nakagawa K. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis. Radiother Oncol. 2011;98:255-260. [PMID: 21074880 DOI: 10.1016/j.radonc.2010.10.021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
100 Li CL, Zhang FL, Wang YD, Han C, Sun GG, Liu Q, Cheng YJ, Jing SW, Yang CR. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett. 2013;5:355-359. [PMID: 23255948 DOI: 10.3892/ol.2012.946] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
101 Hartwig W, Strobel O, Schneider L, Hackert T, Hesse C, Büchler MW, Werner J. Fundus Rotation Gastroplasty vs. Kirschner-Akiyama Gastric Tube in Esophageal Resection: Comparison of Perioperative and Long-Term Results. World J Surg 2008;32:1695-702. [DOI: 10.1007/s00268-008-9648-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
102 Altorki NK, Girardi L, Skinner DB. En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114:948-955; discussion 955-956. [PMID: 9434690 DOI: 10.1016/s0022-5223(97)70009-6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
103 Slim K, Blay JY, Brouquet A, Chatelain D, Comy M, Delpero JR, Denet C, Elias D, Fléjou JF, Fourquier P, Fuks D, Glehen O, Karoui M, Kohneh-Shahri N, Lesurtel M, Mariette C, Mauvais F, Nicolet J, Perniceni T, Piessen G, Regimbeau JM, Rouanet P, sauvanet A, Schmitt G, Vons C, Lasser P, Belghiti J, Berdah S, Champault G, Chiche L, Chipponi J, Chollet P, De Baère T, Déchelotte P, Garcier JM, Gayet B, Gouillat C, Kianmanesh R, Laurent C, Meyer C, Millat B, Msika S, Nordlinger B, Paraf F, Partensky C, Peschaud F, Pocard M, Sastre B, Scoazec JY, Scotté M, Triboulet JP, Trillaud H, Valleur P. [Digestive oncology: surgical practices]. J Chir (Paris) 2009;146 Suppl 2:S11-80. [PMID: 19435621 DOI: 10.1016/S0021-7697(09)72398-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
104 Sakai M, Kato H, Sano A, Tanaka N, Inose T, Kimura H, Sohda M, Nakajima M, Kuwano H. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol 2009;16:2494-501. [PMID: 19526206 DOI: 10.1245/s10434-009-0559-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
105 Wu S, Wang L, Luo H, Xie C, Zhang X, Hu W, Zheng A, Li D, Zhang H, Xie C, Lian X, Du D, Chen M, Bian X, Tan B, Jiang H, Zhang H, Wang J, Jing Z, Xia B, Zhang N, Zhang P, Li W, Zhao F, Tian Z, Liu H, Huang K, Hu J, Xie R, Du L, Li G. Randomised phase III trial of concurrent chemoradiotherapy with extended nodal irradiation and erlotinib in patients with inoperable oesophageal squamous cell cancer. European Journal of Cancer 2018;93:99-107. [DOI: 10.1016/j.ejca.2018.01.085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
106 Wada H, Doki Y, Nishioka K, Ishikawa O, Kabuto T, Yano M, Monden M, Imaoka S. Clinical outcome of esophageal cancer patients with history of gastrectomy. J Surg Oncol. 2005;89:67-74. [PMID: 15660375 DOI: 10.1002/jso.20194] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
107 Kumai Y, Samejima Y, Watanabe M, Yumoto E. Videofluoroscopic evaluation of pharyngeal swallowing dysfunction after esophagectomy with three-field lymph node dissection. Eur Arch Otorhinolaryngol 2017;274:321-6. [PMID: 27423640 DOI: 10.1007/s00405-016-4209-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
108 Wang J, Yang Y, Shafiulla Shaik M, Hu J, Wang K, Gao C, Shan T, Yin D. Three-Field versus Two-Field Lymphadenectomy for Esophageal Squamous Cell Carcinoma: A Meta-analysis. J Surg Res 2020;255:195-204. [PMID: 32563760 DOI: 10.1016/j.jss.2020.05.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Kanaya S, Matsushita T, Komori J, Sarumaru S, Isobe H, Katayama T, Wada Y, Ohtoshi M. Video-assisted transsternal radical esophagectomy: three-field lymphadenectomy without thoracotomy for esophageal cancer. Surg Laparosc Endosc Percutan Tech 1999;9:353-7. [PMID: 10803398 DOI: 10.1097/00019509-199910000-00007] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
110 Mizumoto T, Hiyama T, Oka S, Yorita N, Kuroki K, Kurihara M, Yoshifuku Y, Sanomura Y, Urabe Y, Murakami Y, Arihiro K, Tanaka S, Chayama K. Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas. Dig Dis Sci 2018;63:1605-12. [DOI: 10.1007/s10620-018-5029-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
111 Shirakawa Y, Noma K, Kunitomo T, Hashimoto M, Maeda N, Tanabe S, Sakurama K, Fujiwara T. Initial introduction of robot-assisted, minimally invasive esophagectomy using the microanatomy-based concept in the upper mediastinum. Surg Endosc 2020. [PMID: 33170337 DOI: 10.1007/s00464-020-08154-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Hofstetter W. Commentary: Fluorodeoxyglucose-positron emission tomography/computed tomography for cervical adenopathy in esophageal carcinoma, an option for the selective surgeon. J Thorac Cardiovasc Surg 2020;160:551-2. [PMID: 31955937 DOI: 10.1016/j.jtcvs.2019.11.110] [Reference Citation Analysis]
113 Kutup A, Yekebas EF, Izbicki JR. Current diagnosis and future impact of micrometastases for therapeutic strategies in adenocarcinoma of the esophagus, gastric cardia, and upper gastric third. Recent Results Cancer Res 2010;182:115-25. [PMID: 20676876 DOI: 10.1007/978-3-540-70579-6_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Park S, Hwang Y, Lee HJ, Park IK, Kim YT, Kang CH. Comparison of robot-assisted esophagectomy and thoracoscopic esophagectomy in esophageal squamous cell carcinoma. J Thorac Dis 2016;8:2853-61. [PMID: 27867561 DOI: 10.21037/jtd.2016.10.39] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
115 Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Ectors N. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962-72; discussion 972. [PMID: 15570202 DOI: 10.1097/01.sla.0000145925.70409.d7] [Cited by in Crossref: 269] [Cited by in F6Publishing: 236] [Article Influence: 15.8] [Reference Citation Analysis]
116 Nafteux P, Lerut T, De Hertogh G, Moons J, Coosemans W, Decker G, Van Veer H, De Leyn P. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition? European Journal of Cardio-Thoracic Surgery 2014;45:1001-10. [DOI: 10.1093/ejcts/ezt546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
117 Kaisaki S, Kitayama J, Ishigami H, Nagawa H. Solitary Nodal Recurrence in the Dorsal Area of the Thoracic Aorta After a Curative Resection of Esophageal Cancer: Report of Two Cases. Surg Today 2007;37:243-7. [DOI: 10.1007/s00595-006-3349-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
118 Tanaka K, Yano M, Motoori M, Doki Y, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Ohue M, Yamada T, Ohigashi H, Ishikawa O. The significance of abdominal para-aortic lymph node metastasis in patients with lower thoracic esophageal cancer: PALN metastasis in esophageal cancer. Diseases of the Esophagus 2012;25:146-52. [DOI: 10.1111/j.1442-2050.2011.01222.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Kang X, Chen K, Li Y, Li J, D'Amico TA, Chen X. Personalized targeted therapy for esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(25): 7648-7658 [PMID: 26167067 DOI: 10.3748/wjg.v21.i25.7648] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
120 Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392-400; discussion 400. [PMID: 10493486 DOI: 10.1097/00000658-199909000-00012] [Cited by in Crossref: 411] [Cited by in F6Publishing: 346] [Article Influence: 17.9] [Reference Citation Analysis]
121 Ferahköşe Z, Anadol AZ, Gökbayir H, Dursun A, Oztürk E. Three-field lymph node dissection in the treatment of thoracic esophageal carcinoma: the Turkish experience. Dis Esophagus 2006;19:232-7. [PMID: 16866852 DOI: 10.1111/j.1442-2050.2006.00571.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
122 Doki Y, Ishikawa O, Kabuto T, Hiratsuka M, Sasaki Y, Ohigashi H, Kameyama M, Murata K, Yamada T, Miyashiro I, Yokoyama S, Imaoka S. Possible indication for surgical treatment of squamous cell carcinomas of the esophagus that involve the stomach. Surgery 2003;133:479-85. [PMID: 12773975 DOI: 10.1067/msy.2003.134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
123 Shishido Y, Saito H, Shimizu S, Kono Y, Murakami Y, Miyatani K, Matsunaga T, Yamamoto M, Fukumoto Y, Honjo S, Fujiwara Y. Prognostic significance of platelet × C-reactive protein multiplier in patients with esophageal squamous cell carcinoma. Surg Today 2020;50:185-92. [DOI: 10.1007/s00595-019-01865-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Tan Z, Ma G, Yang H, Zhang L, Rong T, Lin P. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer? J Thorac Oncol. 2014; 9:1214-1221. [PMID: 25157776 DOI: 10.1097/jto.0000000000000216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
125 Reed CE. Surgical Management of Esophageal Carcinoma. The Oncologist 1999;4:95-105. [DOI: 10.1634/theoncologist.4-2-95] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
126 Xi Y, Ma Z, Shen Y, Wang H, Feng M, Tan L, Wang Q. A novel method for lymphadenectomy along the left laryngeal recurrent nerve during thoracoscopic esophagectomy for esophageal carcinoma. J Thorac Dis 2016;8:24-30. [PMID: 26904208 DOI: 10.3978/j.issn.2072-1439.2016.01.11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
127 Akutsu Y, Matsubara H. Lymph node dissection for esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:397-401. [PMID: 23529259 DOI: 10.1007/s11748-013-0237-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
128 Watanabe M, Kono K, Kawaguchi Y, Mizukami Y, Mimura K, Maruyama T, Izawa S, Fujii H. NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma. Dis Esophagus 2010;23:675-81. [PMID: 20545975 DOI: 10.1111/j.1442-2050.2010.01073.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
129 Fan N, Yang H, Zheng J, Chen D, Wang W, Tan Z, Huang Y, Lin P. Comparison of short- and long-term outcomes between 3-field and modern 2-field lymph node dissections for thoracic oesophageal squamous cell carcinoma: a propensity score matching analysis. Interact Cardiovasc Thorac Surg 2019;29:434-41. [PMID: 31135037 DOI: 10.1093/icvts/ivz108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
130 Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. Ann Surg Oncol. 2010;17:804-811. [PMID: 19885698 DOI: 10.1245/s10434-009-0786-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
131 Okamoto N, Ozawa S, Kitagawa Y, Shimizu Y, Kitajima M. Metachronous gastric carcinoma from a gastric tube after radical surgery for esophageal carcinoma. Ann Thorac Surg 2004;77:1189-92. [PMID: 15063232 DOI: 10.1016/j.athoracsur.2003.09.071] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
132 Kyriazanos I, Tachibana M, Yoshimura H, Kinugasa S, Dhar D, Nagasue N. Impact of splenectomy on the early outcome after oesophagectomy for squamous cell carcinoma of the oesophagus. European Journal of Surgical Oncology (EJSO) 2002;28:113-9. [DOI: 10.1053/ejso.2001.1235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
133 Sun L, Zhang H, Wu K. Esophageal Cancer: Current Options for Therapeutic Management. Gastrointest Tumors 2014;1:105-13. [PMID: 26674591 DOI: 10.1159/000362907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
134 Ma GW, Situ DR, Ma QL, Long H, Zhang LJ, Lin P, Rong TH. Three-field vs two-field lymph node dissection for esophageal cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18022-18030 [PMID: 25548502 DOI: 10.3748/wjg.v20.i47.18022] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
135 Kitagawa Y, Fujii H, Mukai M, Kubo A, Kitajima M. Sentinel Lymph Node Mapping in Esophageal and Gastric Cancer. In: Leong SPL, Kitagawa Y, Kitajima M, editors. Selective Sentinel Lymphadenectomy for Human Solid Cancer. Boston: Springer US; 2005. pp. 123-39. [DOI: 10.1007/0-387-23604-x_6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
136 Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol. 2003;4:481-488. [PMID: 12901962 DOI: 10.1016/s1470-2045(03)01167-7] [Cited by in Crossref: 172] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
137 Wang F, Zheng Y, Wang Z, Zheng Q, Huang Q, Liu S. Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy. The Annals of Thoracic Surgery 2017;104:1187-93. [DOI: 10.1016/j.athoracsur.2017.03.081] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
138 Komatsu S, Ichikawa D, Hirajima S, Takeshita H, Shiozaki A, Fujiwara H, Kawaguchi T, Miyamae M, Konishi H, Kubota T, Okamoto K, Yagi N, Otsuji E. Clinical impact of predicting CCND1 amplification using plasma DNA in superficial esophageal squamous cell carcinoma. Dig Dis Sci. 2014;59:1152-1159. [PMID: 24458211 DOI: 10.1007/s10620-013-3005-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
139 Shimada Y, Sato F, Maeda M, Watanabe G, Nagatani S, Kaganoi J, Hashimoto Y, Kan T, Li Z, Imamura M. Validity of intraoperative pathological diagnosis of paratracheal lymph node as a strategy for selection of patients for cervical lymph node dissection during esophagectomy. Dis Esophagus 2003;16:246-51. [PMID: 14641319 DOI: 10.1046/j.1442-2050.2003.00338.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
140 Wang D, Yang Y, Zhu J, Li B, Chen J, Yin Y. 3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation. Technol Cancer Res Treat 2011;10:487-94. [PMID: 21895033 DOI: 10.7785/tcrt.2012.500225] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
141 Oshiro H, Osaka Y, Tachibana S, Aoki T, Tsuchiya T, Nagao T. Retrograde Lymphatic Spread of Esophageal Cancer: A Case Report. Medicine (Baltimore) 2015;94:e1139. [PMID: 26166121 DOI: 10.1097/MD.0000000000001139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
142 Gao S, Li J, Feng X, Shi S, He J. Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus. Sci Rep 2016;6:23804. [PMID: 27033424 DOI: 10.1038/srep23804] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
143 Natsugoe S, Matsumoto M, Nakashima S, Okumura H, Miyazono F, Kijima F, Ishigami S, Aridome K, Kusano C, Baba M, Takao S, Aikou T. Effect of neoadjuvant chemotherapy for lymph node micrometastasis and tumor cell microinvolvement in the patients with esophageal carcinoma. Cancer Lett 2000;159:119-25. [PMID: 10996722 DOI: 10.1016/s0304-3835(00)00505-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
144 Iinuma H, Fukushima R, Inaba T, Tamura J, Inoue T, Ogawa E, Horikawa M, Ikeda Y, Matsutani N, Takeda K. Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients. J Transl Med. 2014;12:84. [PMID: 24708624 DOI: 10.1186/1479-5876-12-84] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
145 Kitagawa Y, Fujii H, Mukai M, Kubota T, Ando N, Ozawa S, Ohtani Y, Furukawa T, Yoshida M, Nakamura E, Matsuda J, Shimizu Y, Nakamura K, Kumai K, Kubo A, Kitajima M. Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am 2002;11:293-304. [PMID: 12424851 DOI: 10.1016/s1055-3207(02)00005-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
146 Sakai M, Suzuki S, Sano A, Tanaka N, Inose T, Sohda M, Nakajima M, Miyazaki T, Kuwano H. Significance of Lymph Node Capsular Invasion in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2012;19:1911-7. [DOI: 10.1245/s10434-012-2232-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
147 Shang QX, Yang YS, Xu LY, Li EM, Hu WP, Chen LQ. Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. J Thorac Dis 2017;9:4461-76. [PMID: 29268516 DOI: 10.21037/jtd.2017.10.60] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
148 Demeester SR. New Options for the Therapy of Barrett’s High-Grade Dysplasia and Intramucosal Adenocarcinoma: Endoscopic Mucosal Resection and Ablation versus Vagal-Sparing Esophagectomy. The Annals of Thoracic Surgery 2008;85:S747-50. [DOI: 10.1016/j.athoracsur.2007.10.102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
149 Niwa Y, Koike M, Hattori M, Iwata N, Takami H, Hayashi M, Tanaka C, Kobayashi D, Kanda M, Yamada S, Fujii T, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y. The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2016;23:611-8. [PMID: 26289807 DOI: 10.1245/s10434-015-4819-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
150 Ye T, Sun Y, Zhang Y, Zhang Y, Chen H. Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis. Ann Thorac Surg 2013;96:1933-41. [PMID: 24055234 DOI: 10.1016/j.athoracsur.2013.06.050] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
151 Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Fujishiro M, Oyama T, Uno T; The Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Efficacy of lymph node dissection for each station based on esophageal tumor location. Esophagus 2016;13:138-45. [DOI: 10.1007/s10388-015-0503-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
152 Tanaka T, Fujita H, Matono S, Nagano T, Nishimura K, Murata K, Shirouzu K, Suzuki G, Hayabuchi N, Yamana H. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Dis Esophagus 2010;23:646-51. [PMID: 20545979 DOI: 10.1111/j.1442-2050.2010.01069.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
153 Lazarescu I, Thureau S, Nkhali L, Pradier O, Dubray B. Définition du volume cible anatomoclinique pour l’irradiation des cancers de l’œsophage. Cancer/Radiothérapie 2013;17:453-60. [DOI: 10.1016/j.canrad.2013.07.145] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
154 Kinoshita Y, Udagawa H, Tsutsumi K, Ueno M, Nakamura T, Akiyama H, Takahashi K, Kajiyama Y, Tsurumaru M. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000;127:185-92. [PMID: 10686984 DOI: 10.1067/msy.2000.102048] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
155 Cuesta MA, van der Peet DL, Gisbertz SS, Straatman J. Mediastinal lymphadenectomy for esophageal cancer: Differences between two countries, Japan and the Netherlands. Ann Gastroenterol Surg 2018;2:176-81. [PMID: 29863178 DOI: 10.1002/ags3.12172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
156 Nakamura M, Kido Y, Hosoya Y, Yano M, Nagai H, Monden M. Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer. Surg Today. 2007;37:379-382. [PMID: 17468818 DOI: 10.1007/s00595-006-3413-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
157 Stockeld D, Falkmer U, Falkmer S, Backman L, Granström L, Fagerberg J. Response to chemoradiatiotherapy in squamous cell carcinoma of the esophagus: evaluation of some prognostic factors. Clin Exp Gastroenterol 2009;2:41-7. [PMID: 21694826 DOI: 10.2147/ceg.s4402] [Reference Citation Analysis]
158 Lerut T, Nafteux P, Moons J, Coosemans W, Decker G, De Leyn P, Van Raemdonck D. Quality in the surgical treatment of cancer of the esophagus and gastroesophageal junction. European Journal of Surgical Oncology (EJSO) 2005;31:587-94. [DOI: 10.1016/j.ejso.2005.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
159 Couper G. Jejunostomy after oesophagectomy: a review of evidence and current practice. Proc Nutr Soc. 2011;70:316-320. [PMID: 21781359 DOI: 10.1017/s0029665111000553] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
160 Bagheri R, Naghavi F, Kakhki VRD, Zakavi SR, Fattahi AS, Jafarian AH, Haghi SZ, Sadeghi R. Sentinel node mapping in esophageal squamous cell carcinoma using intra-operative combined blue dye and radiotracer techniques. Esophagus 2013;10:211-6. [DOI: 10.1007/s10388-013-0390-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
161 Fang WT, Chen WH. Current trends in extended lymph node dissection for esophageal carcinoma. Asian Cardiovasc Thorac Ann. 2009;17:208-213. [PMID: 19592560 DOI: 10.1177/0218492309103332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
162 Song WA, Fan BS, Di SY, Liu JQ, Zhao JH, Chen SY, Yue CY, Zhou SH, Gong TQ. Three-Field Lymphadenectomy in Minimally Invasive Esophagectomy for Squamous Cell Carcinoma. Ann Thorac Surg 2021;112:928-34. [PMID: 33152329 DOI: 10.1016/j.athoracsur.2020.09.022] [Reference Citation Analysis]
163 Li ZX, Li XD, Liu XB, Xing WQ, Sun HB, Wang ZF, Zhang RX, Li Y. Clinical evaluation of right recurrent laryngeal nerve nodes in thoracic esophageal squamous cell carcinoma. J Thorac Dis 2020;12:3622-30. [PMID: 32802441 DOI: 10.21037/jtd-20-774] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003;57:425-433. [PMID: 12957254 DOI: 10.1016/s0360-3016(03)00585-6] [Cited by in Crossref: 154] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
165 Oshikiri T, Yasuda T, Harada H, Goto H, Oyama M, Hasegawa H, Ohara T, Sendo H, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. A new method (the "Bascule method") for lymphadenectomy along the left recurrent laryngeal nerve during prone esophagectomy for esophageal cancer. Surg Endosc 2015;29:2442-50. [PMID: 25303923 DOI: 10.1007/s00464-014-3919-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
166 Tachibana M, Yoshimura H, Kinugasa S, Shibakita M, Dhar D, Ueda S, Fujii T, Nagasue N. Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. European Journal of Surgical Oncology (EJSO) 2003;29:580-7. [DOI: 10.1016/s0748-7983(03)00111-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
167 Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K, Baba H. RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. Br J Cancer. 2012;107:1233-1238. [PMID: 22955852 DOI: 10.1038/bjc.2012.396] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
168 Otsuka K, Murakami M, Goto S, Ariyoshi T, Yamashita T, Saito A, Kohmoto M, Kato R, Lefor AK, Aoki T. Minimally invasive esophagectomy and radical lymph node dissection without recurrent laryngeal nerve paralysis. Surg Endosc 2020;34:2749-57. [PMID: 32016515 DOI: 10.1007/s00464-020-07372-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
169 Takeuchi M, Takeuchi H, Kawakubo H, Kitagawa Y. Update on the indications and results of sentinel node mapping in upper GI cancer. Clin Exp Metastasis. 2018;35:455-461. [PMID: 30132238 DOI: 10.1007/s10585-018-9934-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
170 Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D. Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surgical Oncology 2001;10:113-22. [DOI: 10.1016/s0960-7404(01)00027-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
171 Natsugoe S, Mueller J, Stein HJ, Feith M, H�fler H, Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998;83:858-66. [DOI: 10.1002/(sici)1097-0142(19980901)83:5<858::aid-cncr9>3.0.co;2-e] [Cited by in Crossref: 116] [Article Influence: 4.8] [Reference Citation Analysis]
172 Yip HC, Shirakawa Y, Cheng CY, Huang CL, Chiu PWY. Recent advances in minimally invasive esophagectomy for squamous esophageal cancer. Ann N Y Acad Sci 2020;1482:113-20. [PMID: 32783237 DOI: 10.1111/nyas.14461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
173 Hattori K, Kajiyama Y, Tsurumaru M. Mutation of the p53 gene predicts lymph node metastases in Japanese patients with esophageal carcinoma: DNA and immunohistochemical analyses. Dis Esophagus 2003;16:301-6. [PMID: 14641293 DOI: 10.1111/j.1442-2050.2003.00351.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
174 Fujita H. History of lymphadenectomy for esophageal cancer and the future prospects for esophageal cancer surgery. Surg Today 2015;45:140-9. [PMID: 24519395 DOI: 10.1007/s00595-014-0841-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
175 Ali AH, Carey EJ, Lindor KD. Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med. 2015;3:5. [PMID: 25705637 DOI: 10.3978/j.issn.2305-5839] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
176 Mao Y, Yu Z, You B, Fang W, Badgwell B, Berry MF, Ceppa DP, Chen C, Chen H, Cuesta MA, D'Journo XB, Eslick GD, Fu J, Fu X, Gao S, He J, He J, Huang Y, Jiang G, Jiang Z, Kim JY, Li D, Li H, Li S, Liu D, Liu L, Liu Y, Li X, Li Y, Mao W, Molena D, Morse CR, Novoa NM, Tan L, Tan Q, Toker A, Tong T, Wang Q, Weksler B, Xu L, Xu S, Yan T, Zhang L, Zhang X, Zhang X, Zhang Z, Zhi X, Zhou Q. Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma. J Thorac Dis 2019;11:319-28. [PMID: 30863610 DOI: 10.21037/jtd.2018.12.07] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
177 Whooley BP, Wong J. Intrathoracic Oesophageal Anastomosis: Is it Worth the Risk? ANZ J Surg 2000;70:677-80. [DOI: 10.1046/j.1440-1622.2000.01923.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Baba Y, Watanabe M, Shigaki H, Iwagami S, Ishimoto T, Iwatsuki M, Baba H. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery 2013;153:234-41. [DOI: 10.1016/j.surg.2012.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
179 Noguchi M, Miyazaki I. Extended lymph node dissection in gastrointestinal cancer. J Surg Oncol 1997;65:57-65. [DOI: 10.1002/(sici)1096-9098(199705)65:1<57::aid-jso12>3.0.co;2-p] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
180 Motoori M, Yano M, Tanaka K, Kishi K, Takahashi H, Inoue M, Saito T, Sugimura K, Fujiwara Y, Ishikawa O, Sakon M. Intraoperative photodynamic diagnosis of lymph node metastasis in esophageal cancer patients using 5-aminolevulinic acid. Oncol Lett 2015;10:3035-9. [PMID: 26722285 DOI: 10.3892/ol.2015.3685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
181 Shimada H, Shiratori T, Okazumi S, Matsubara H, Nabeya Y, Shuto K, Akutsu Y, Hayashi H, Isono K, Ochiai T. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience. J Am Coll Surg 2008;206:48-56. [PMID: 18155568 DOI: 10.1016/j.jamcollsurg.2007.06.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
182 Wang WP, Ni PZ, Yang YS, He SL, Hu WP, Chen LQ. The Role and Prognostic Significance of Aortopulmonary, Anterior Mediastinal, and Tracheobronchial Lymph Nodes in Esophageal Cancer: Update of the Eighth-Edition TNM Staging System (2018). Ann Surg Oncol 2019;26:1005-11. [PMID: 30511093 DOI: 10.1245/s10434-018-07086-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
183 Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, Uenosono Y, Ishigami S, Owaki T, Aikou T. Individualization of lymphadenectomy in superficial esophageal squamous cell cancer. Esophagus 2006;3:41-5. [DOI: 10.1007/s10388-006-0070-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
184 Griffith JF, Chan AC, Ahuja AT, Leung SF, Chow LT, Chung SC, Metreweli C. Neck ultrasound in staging squamous oesophageal carcinoma - a high yield technique. Clin Radiol 2000;55:696-701. [PMID: 10988048 DOI: 10.1053/crad.2000.0502] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
185 Komukai S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Significance of immunohistochemical nodal micrometastasis as a prognostic indicator in potentially curable oesophageal carcinoma. British Journal of Surgery 2002;89:213-9. [DOI: 10.1046/j.1365-2168.2002.01981.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
186 Wang W, Liu F, Hu T, Wang C. Matched-pair comparisons of minimally invasive esophagectomy versus open esophagectomy for resectable esophageal cancer: A systematic review and meta-analysis protocol. Medicine (Baltimore) 2018;97:e11447. [PMID: 29995799 DOI: 10.1097/MD.0000000000011447] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
187 Lerut T, Coosemans W, De Leyn P, Van Raemdonck D, Nafteux P, Moons J. Optimizing Treatment of Carcinoma of the Esophagus and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2001;10:863-84. [DOI: 10.1016/s1055-3207(18)30037-1] [Cited by in Crossref: 17] [Article Influence: 0.8] [Reference Citation Analysis]
188 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M, Yamamura T. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. Oncol Rep 2012;28:446-52. [PMID: 22664791 DOI: 10.3892/or.2012.1847] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
189 Goense L, Meziani J, van Rossum PSN, Wessels FJ, Lam MGEH, van Hillegersberg R, Ruurda JP. Cervical ultrasonography has no additional value over negative 18F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer. Eur Radiol 2018;28:2031-7. [PMID: 29218619 DOI: 10.1007/s00330-017-5136-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
190 Fang W, Igaki H, Tachimori Y, Sato H, Daiko H, Kato H. Three-field lymph node dissection for esophageal cancer in elderly patients over 70 years of age. The Annals of Thoracic Surgery 2001;72:867-71. [DOI: 10.1016/s0003-4975(01)02896-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
191 Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M. Clinical patterns of metastasis. Cancer Metastasis Rev 2006;25:221-32. [PMID: 16770534 DOI: 10.1007/s10555-006-8502-8] [Cited by in Crossref: 92] [Cited by in F6Publishing: 75] [Article Influence: 5.8] [Reference Citation Analysis]
192 Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann Thorac Surg. 2007;83:1265-1272. [PMID: 17383324 DOI: 10.1016/j.athoracsur.2006.12.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
193 Wang X, Liu X, Li D, Wang X, Huang W, Li B. Concurrent Selective Lymph Node Radiotherapy and S-1 Plus Cisplatin for Esophageal Squamous Cell Carcinoma: A Phase II Study. Ann Surg Oncol 2019;26:1886-92. [PMID: 30805810 DOI: 10.1245/s10434-019-07264-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
194 Shimada Y, Imamura M, Watanabe G, Uchida S, Harada H, Makino T, Kano M. Prognostic factors of oesophageal squamous cell carcinoma from the perspective of molecular biology. Br J Cancer. 1999;80:1281-1288. [PMID: 10376985 DOI: 10.1038/sj.bjc.6990499] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 2.7] [Reference Citation Analysis]
195 Yasuda T, Yano M, Miyata H, Yamasaki M, Takiguchi S, Fujiwara Y, Doki Y. Evaluation of Dysphagia and Diminished Airway Protection after Three-Field Esophagectomy and a Remedy. World J Surg 2013;37:416-23. [DOI: 10.1007/s00268-012-1822-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
196 Sato H, Tsubosa Y, Ugumori T. Esophagectomy with three-field lymph node dissection for esophageal carcinoma with a nonrecurrent inferior laryngeal nerve. Jpn J Thorac Cardiovasc Surg 2005;53:502-4. [PMID: 16200893 DOI: 10.1007/s11748-005-0096-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
197 Jeon YJ, Cho JH, Lee HK, Kim HK, Choi YS, Zo JI, Shim YM. Management of patients with bilateral recurrent laryngeal nerve paralysis following esophagectomy. Thorac Cancer 2021;12:1851-6. [PMID: 33955175 DOI: 10.1111/1759-7714.13940] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 Nakamura T, Hatooka S, Kodaira T, Tachibana H, Tomita N, Nakahara R, Inokuchi H, Mizoguchi N, Takada A, Shinoda M, Fuwa N. Determination of the irradiation field for clinical T1-T3N0M0 thoracic/abdominal esophageal cancer based on the postoperative pathological results. Jpn J Clin Oncol 2009;39:86-91. [PMID: 19042946 DOI: 10.1093/jjco/hyn131] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
199 Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Esophageal cancer. Curr Probl Surg 1997;34:765-834. [PMID: 9365422 DOI: 10.1016/s0011-3840(97)80015-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
200 Sharma P, Jain S, Karunanithi S, Pal S, Julka PK, Thulkar S, Malhotra A, Bal C, Kumar R. Diagnostic accuracy of 18F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma. Eur J Nucl Med Mol Imaging 2014;41:1084-92. [DOI: 10.1007/s00259-013-2664-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
201 Guo W, Ma Z, Zhao YP, Jiang YG. Controllable metastasis: the trap for the esophageal cancer cells? Med Hypotheses 2010;74:1000-1. [PMID: 20129740 DOI: 10.1016/j.mehy.2010.01.017] [Reference Citation Analysis]
202 Tsunoda S, Shinohara H, Kanaya S, Okabe H, Tanaka E, Obama K, Hosogi H, Hisamori S, Sakai Y. Mesenteric excision of upper esophagus: a concept for rational anatomical lymphadenectomy of the recurrent laryngeal nodes in thoracoscopic esophagectomy. Surg Endosc 2020;34:133-41. [PMID: 31011861 DOI: 10.1007/s00464-019-06741-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
203 Akiyama S, Sekiguchi H, Fujiwara M, Hibi K, Kasai Y, Kondo K, Ito K, Takagi H. Intra-aortic ultrasonography in advanced esophageal cancer. Semin Surg Oncol 1997;13:234-7. [PMID: 9229409 DOI: 10.1002/(sici)1098-2388(199707/08)13:4<234::aid-ssu3>3.0.co;2-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
204 Shaheen O, Ghibour A, Alsaid B. Esophageal Cancer Metastases to Unexpected Sites: A Systematic Review. Gastroenterol Res Pract. 2017;2017:1657310. [PMID: 28659974 DOI: 10.1155/2017/1657310] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
205 Créhange G, Quivrin M, Vulquin N, Serre A, Maingon P. Chimioradiothérapie des cancers de l’œsophage : quelles aires ganglionnaires faut-il irradier ? Cancer/Radiothérapie 2014;18:577-82. [DOI: 10.1016/j.canrad.2014.07.150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
206 Kitagawa Y, Kitajima M. Lymphatic mapping for upper gastrointestinal malignancies. Seminars in Oncology 2004;31:409-14. [DOI: 10.1053/j.seminoncol.2004.03.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
207 Pifarré-montaner P, Fernández-león A, de Juan R, del Ama-salvador M, Galán M, Gámez-cenzano C, Sans M. Impacto clínico de la PET/TAC con 18F-FDG en el manejo terapéutico de pacientes con diagnóstico inicial de cáncer de esófago. Revista Española de Medicina Nuclear 2009;28:101-5. [DOI: 10.1016/s0212-6982(09)71351-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
208 Takeuchi H, Kitagawa Y. Sentinel node navigation surgery in esophageal cancer. Ann Gastroenterol Surg 2019;3:7-13. [PMID: 30697605 DOI: 10.1002/ags3.12206] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
209 Natsugoe S, Nakashima S, Matsumoto M, Sakita H, Sakamoto F, Okumura H, Baba M, Yoshinaka H, Takao S, Aikou T. Biologic and imaging diagnosis of lymph node metastasis in esophageal carcinoma. J Surg Oncol. 2002;81:25-32. [PMID: 12210023 DOI: 10.1002/jso.10151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
210 Wang J, Chang J, Yu H, Wu X, Wang H, Li W, Ji D, Peng W. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus. Cancer Chemother Pharmacol 2013;71:905-11. [DOI: 10.1007/s00280-013-2081-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
211 Tachibana M, Kotoh T, Kinugasa S, Kumar Dhar D, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N. Esophageal Cancer With Cirrhosis of the Liver: Results of Esophagectomy in 18 Consecutive Patients. Ann Surg Oncol 2000;7:758-63. [DOI: 10.1007/s10434-000-0758-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
212 Kawakubo H. Surgery Transthoracic Esophagectomy. In: Ando N, editor. Esophageal Squamous Cell Carcinoma. Singapore: Springer; 2020. pp. 161-75. [DOI: 10.1007/978-981-15-4190-2_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Robertson GSM, Lloyd DM, Wicks ACB, Veitch PS. No obvious advantages for thoracoscopic two-stage oesophagectomy. British Journal of Surgery 1996;83:675-8. [DOI: 10.1002/bjs.1800830527] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
214 Miyazaki T, Kuwano H, Kato H, Yoshikawa M, Ojima H, Tsukada K. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg 2002;26:1319-23. [DOI: 10.1007/s00268-002-6366-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 3.3] [Reference Citation Analysis]
215 Kawakubo H, Takeuchi H, Kitagawa Y. Current status and future perspectives on minimally invasive esophagectomy. Korean J Thorac Cardiovasc Surg. 2013;46:241-248. [PMID: 24003404 DOI: 10.5090/kjtcs.2013.46.4.241] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
216 Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83. [PMID: 12170022 DOI: 10.1097/00000658-200208000-00005] [Cited by in Crossref: 295] [Cited by in F6Publishing: 254] [Article Influence: 14.8] [Reference Citation Analysis]
217 Powell AGMT, Hughes DL, Brown J, Larsen M, Witherspoon J, Lewis WG. Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. Diseases of the Esophagus 2017;30:1-8. [DOI: 10.1093/dote/dow039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
218 Pandey D, Pandey R, Garg PK. Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit. Annals of Surgery 2017;265:e41-2. [DOI: 10.1097/sla.0000000000001160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
219 Kawaguchi Y, Kono K, Mimura K, Mitsui F, Sugai H, Akaike H, Fujii H. Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. Br J Cancer 2007;97:494-501. [PMID: 17622245 DOI: 10.1038/sj.bjc.6603885] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
220 Archer V, Mulholland P, Stocken D, Darnton S, Ferry D. Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus. Clinical Oncology 2001;13:164-9. [DOI: 10.1053/clon.2001.9246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
221 Zeng J, Liu JS. Quality of life after three kinds of esophagectomy for cancer. World J Gastroenterol 2012; 18(36): 5106-5113 [PMID: 23049222 DOI: 10.3748/wjg.v18.i36.5106] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
222 Mariette C, Fabre S, Balon J, Piessen G, Lamblin A, Triboulet J. Patients vivants à 5 ans après œsophagectomie curative pour cancer. Annales de Chirurgie 2003;128:536-42. [DOI: 10.1016/s0003-3944(03)00192-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
223 Yamashita H, Okuma K, Seto Y, Mori K, Kobayashi S, Wakui R, Ohtomo K, Nakagawa K. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma. J Surg Oncol 2009;100:435-41. [PMID: 19653240 DOI: 10.1002/jso.21361] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
224 Motoori M, Yano M, Yasuda T, Miyata H, Peng Y, Yamasaki M, Shiraishi O, Masuzawa T, Tanaka K, Ishikawa O, Shiozaki H, Doki Y. Chemotherapy-induced toxicities and treatment efficacy in advanced esophageal cancer treated with neoadjuvant chemotherapy followed by surgery. Esophagus 2011;8:81-7. [DOI: 10.1007/s10388-011-0267-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
225 Suda K, Ishida Y, Kawamura Y, Inaba K, Kanaya S, Teramukai S, Satoh S, Uyama I. Robot-assisted thoracoscopic lymphadenectomy along the left recurrent laryngeal nerve for esophageal squamous cell carcinoma in the prone position: technical report and short-term outcomes. World J Surg. 2012;36:1608-1616. [PMID: 22392356 DOI: 10.1007/s00268-012-1538-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
226 Dabbagh Kakhki VR, Bagheri R, Tehranian S, Shojaei P, Gholami H, Sadeghi R, Krag DN. Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature. Surg Today. 2014;44:607-619. [PMID: 23715926 DOI: 10.1007/s00595-013-0590-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
227 Komukai S, Nishimaki T, Watanabe H, Ajioka Y, Suzuki T, Hatakeyama K. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes. Surgery. 2000;127:40-46. [PMID: 10660757 DOI: 10.1067/msy.2000.102754] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 2.7] [Reference Citation Analysis]
228 Mine S, Watanabe M, Kumagai K, Okamura A, Yamashita K, Hayami M, Yuda M, Imamura Y, Ishizuka N. Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus. British Journal of Surgery 2018;105:1793-8. [DOI: 10.1002/bjs.10960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
229 Kajiyama Y, Hattori K, Tomita N, Amano T, Iwanuma Y, Narumi K, Udagawa H, Tsurumaru M. Histopathologic effects of neoadjuvant therapies for advanced squamous cell carcinoma of the esophagus: multivariate analysis of predictive factors and p53 overexpression. Dis Esophagus. 2002;15:61-66. [PMID: 12060045 DOI: 10.1046/j.1442-2050.2002.00222.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
230 Shao L, Ye T, Ma L, Lin D, Hu H, Sun Y, Zhang Y, Xiang J, Chen H. Three-field versus two-field lymph node dissection for thoracic esophageal squamous cell carcinoma: a propensity score-matched comparison. J Thorac Dis 2018;10:2924-32. [PMID: 29997958 DOI: 10.21037/jtd.2018.05.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
231 Law S, Wong J. Esophageal cancer. Curr Opin Gastroenterol 2000;16:386-91. [PMID: 17031106 DOI: 10.1097/00001574-200007000-00016] [Reference Citation Analysis]
232 Law S, Wong J. Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. J Gastroenterol Hepatol 2002;17:374-81. [PMID: 11982715 DOI: 10.1046/j.1440-1746.2002.02728.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
233 Ilson DH, Minsky BD. CHEMOTHERAPY AND RADIOTHERAPY AS PRIMARY TREATMENT OF ESOPHAGEAL CANCER. Pearson's Thoracic and Esophageal Surgery. Elsevier; 2008. pp. 509-26. [DOI: 10.1016/b978-0-443-06861-4.50198-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
234 Tachimori Y. Pattern of lymph node metastases of squamous cell esophageal cancer based on the anatomical lymphatic drainage system: efficacy of lymph node dissection according to tumor location. J Thorac Dis. 2017;9:S724-S730. [PMID: 28815068 DOI: 10.21037/jtd.2017.06.19] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
235 Bhansali M, Vaidya J, Bhatt R, Patil P, Badwe R, Desai P. Chemotherapy for carcinoma of the esophagus: A comparison of evidence from meta-analyses of randomized trials and of historical control studies. Annals of Oncology 1996;7:355-9. [DOI: 10.1093/oxfordjournals.annonc.a010601] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
236 Park SY, Suh JW, Kim DJ, Park JC, Kim EH, Lee CY, Lee JG, Paik HC, Chung KY. Near-Infrared Lymphatic Mapping of the Recurrent Laryngeal Nerve Nodes in T1 Esophageal Cancer. Ann Thorac Surg 2018;105:1613-20. [PMID: 29518388 DOI: 10.1016/j.athoracsur.2018.01.083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
237 Shim YM, Kim HK, Kim K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010;5:707-12. [PMID: 20421764 DOI: 10.1097/JTO.0b013e3181d3ccb2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
238 Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol 2009;2:252-6. [PMID: 26192419 DOI: 10.1007/s12328-009-0098-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
239 Kitagawa Y, Saha S. Current status and future clinical applications of lymphatic mapping in gastrointestinal cancer. J Gastroenterol 2007;42:927-31. [PMID: 18085348 DOI: 10.1007/s00535-007-2127-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
240 de Manzoni G, Pedrazzani C, Laterza E, Pasini F, Grandinetti A, Bernini M, Ruzzenente A, Zerman G, Tomezzoli A, Cordiano C. Induction Chemoradiotherapy for Squamous Cell Carcinoma of the Thoracic Esophagus: Impact of Increased Dosage on Long-Term Results. The Annals of Thoracic Surgery 2005;80:1176-83. [DOI: 10.1016/j.athoracsur.2005.02.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
241 Gockel I, Heckhoff S, Messow CM, Kneist W, Junginger T. Transhiatal and transthoracic resection in adenocarcinoma of the esophagus: does the operative approach have an influence on the long-term prognosis. World J Surg Oncol. 2005;3:40. [PMID: 15978128 DOI: 10.1186/1477-7819-3-40] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
242 Kitagawa Y, Mukai M, Nakahara T, Saikawa Y, Takeuchi H, Kubo A, Kitajima M. Clinical significance of molecular metastasis in sentinel lymph nodes of esophageal cancer. Esophagus 2007;4:19-22. [DOI: 10.1007/s10388-006-0102-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
243 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145:12S21-9. [PMID: 22794068 DOI: 10.1016/S0021-7697(08)45005-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
244 Onozawa M, Nihei K, Ishikura S, Minashi K, Yano T, Muto M, Ohtsu A, Ogino T. Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol. 2009;92:266-269. [PMID: 18952308 DOI: 10.1016/j.radonc.2008.09.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
245 Oshikiri T, Yasuda T, Hasegawa H, Yamamoto M, Kanaji S, Yamashita K, Matsuda T, Sumi Y, Nakamura T, Fujino Y, Tominaga M, Suzuki S, Kakeji Y. Short-term outcomes and one surgeon’s learning curve for thoracoscopic esophagectomy performed with the patient in the prone position. Surg Today 2017;47:313-9. [DOI: 10.1007/s00595-016-1378-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
246 Natsugoe S, Matsumoto M, Okumura H, Ishigami S, Uenosono Y, Owaki T, Takao S, Aikou T. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J Surg. 2005;29:46-49. [PMID: 15592914 DOI: 10.1007/s00268-004-7525-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
247 Mariette C, Piessen G, Vons C. [Not Available]. J Chir (Paris) 2008;145S4:12S21-9. [PMID: 22793981 DOI: 10.1016/S0021-7697(08)74718-5] [Reference Citation Analysis]
248 Iizuka N, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Oka M. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett. 1999;138:139-144. [PMID: 10378785 DOI: 10.1016/s0304-3835(98)00387-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
249 Bhatia KS, Griffith JF, Ahuja AT. Stomach cancer: prevalence and significance of neck nodal metastases on sonography. Eur Radiol. 2009;19:1968-1972. [PMID: 19259677 DOI: 10.1007/s00330-009-1372-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
250 Urschel JD. Does the interponat affect outcome after esophagectomy for cancer? Dis Esophagus. 2001;14:124-130. [PMID: 11553222 DOI: 10.1046/j.1442-2050.2001.00169.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
251 Matsuda S, Kawakubo H, Takeuchi H, Hayashi M, Mayanagi S, Takemura R, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg 2020;107:705-11. [PMID: 32077101 DOI: 10.1002/bjs.11487] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
252 Yamashita K, Watanabe M, Mine S, Toihata T, Fukudome I, Okamura A, Yuda M, Hayami M, Ishizuka N, Imamura Y. Minimally invasive esophagectomy attenuates the postoperative inflammatory response and improves survival compared with open esophagectomy in patients with esophageal cancer: a propensity score matched analysis. Surg Endosc 2018;32:4443-50. [DOI: 10.1007/s00464-018-6187-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
253 Zielinski J, Kruszewski WJ, Jaworski R, Haponiuk I, Irga N, Zygon J, Kopacz A, Jaskiewicz J. Rare oesophageal tumours: experience of one centre. Eur Surg 2012;44:361-5. [PMID: 23440953 DOI: 10.1007/s10353-012-0165-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
254 Kikuchi H, Endo H, Yamamoto H, Ozawa S, Miyata H, Kakeji Y, Matsubara H, Doki Y, Kitagawa Y, Takeuchi H. Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy: Analysis of Esophagectomies in the Japanese National Clinical Database. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12501] [Reference Citation Analysis]
255 Imamura Y, Hayashi N, Sato N, Kinoshita K, Kurashige J, Saito S, Hirashima K, Karashima R, Hiyoshi Y, Nagai Y, Watanabe M, Baba H. Extensive lymphatic spread of cancer cells in patients with thoracic esophageal squamous cell carcinoma: Detection of CEA-mRNA in the three-field lymph nodes: Lymphatic Spread of Esophageal Cancer. J Surg Oncol 2010;102:509-15. [DOI: 10.1002/jso.21621] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
256 Makino T, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Nakajima K, Higuchi I, Hatazawa J, Mori M, Doki Y. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma. Surgery. 2010;148:908-918. [PMID: 20378140 DOI: 10.1016/j.surg.2010.02.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
257 Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40. [PMID: 28815069 DOI: 10.21037/jtd.2017.03.171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
258 Shimada H, Okazumi S, Matsubara H, Shiratori T, Akutsu Y, Nabeya Y, Tanizawa T, Matsushita K, Hayashi H, Isono K, Ochiai T. Long-term Results after Dissection of Positive Thoracic Lymph Nodes in Patients with Esophageal Squamous Cell Carcinoma. World J Surg 2008;32:255-61. [DOI: 10.1007/s00268-007-9213-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
259 Sunada F, Itabashi M, Ohkura H, Okumura T. p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy. World J Gastroenterol 2005; 11(36): 5696-5700 [PMID: 16237768 DOI: 10.3748/wjg.v11.i36.5696] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
260 Lehnert T. Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg. 1999;86:727-739. [PMID: 10383570 DOI: 10.1046/j.1365-2168.1999.01152.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
261 Gockel I, Kneist W, Junginger T. Influence of splenectomy on perioperative morbidity and long-term survival after esophagectomy in patients with esophageal carcinoma. Diseases of the Esophagus 2005;18:311-5. [DOI: 10.1111/j.1442-2050.2005.00512.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
262 Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K, Miyoshi T, Kondo K, Bando Y, Ohnishi Y. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer. 2009;125:952-960. [PMID: 19462449 DOI: 10.1002/ijc.24433] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
263 Heeren P, Kelder W, Blondeel I, van Westreenen H, Hollema H, Plukker J. Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction. European Journal of Surgical Oncology (EJSO) 2005;31:270-6. [DOI: 10.1016/j.ejso.2004.12.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
264 Matsuda S, Takeuchi H, Kawakubo H, Ando N, Kitagawa Y. Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan. Ann Thorac Cardiovasc Surg 2016;22:275-83. [PMID: 27384595 DOI: 10.5761/atcs.ra.16-00111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
265 Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 2004;239:483-90. [PMID: 15024309 DOI: 10.1097/01.sla.0000118562.97742.29] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
266 Hashimoto J, Kato K, Ito Y, Kojima T, Akimoto T, Daiko H, Hamamoto Y, Matsushita H, Katano S, Hara H, Tanaka Y, Saito Y, Nagashima K, Igaki H. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma. Int J Clin Oncol 2019;24:60-7. [DOI: 10.1007/s10147-018-1336-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
267 Kim DJ, Park SY, Lee S, Kim HI, Hyung WJ. Feasibility of a robot-assisted thoracoscopic lymphadenectomy along the recurrent laryngeal nerves in radical esophagectomy for esophageal squamous carcinoma. Surg Endosc. 2014;28:1866-1873. [PMID: 24464384 DOI: 10.1007/s00464-013-3406-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
268 Guo X, Ye B, Yang Y, Sun Y, Hua R, Zhang X, Mao T, Li Z. Impact of unplanned events on early postoperative results of minimally invasive esophagectomy. Thorac Cancer 2018;9:94-8. [PMID: 29083537 DOI: 10.1111/1759-7714.12544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
269 Lerut T. Oesophageal carcinoma—past and present studies. European Journal of Surgical Oncology (EJSO) 1996;22:317-23. [DOI: 10.1016/s0748-7983(96)90044-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
270 Nishimaki T, Suzuki T, Kanda T, Obinata I, Komukai S, Hatakeyama K. Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery 1999;125:142-7. [DOI: 10.1016/s0039-6060(99)70257-6] [Cited by in Crossref: 41] [Article Influence: 1.8] [Reference Citation Analysis]
271 Kunisaki C, Kosaka T, Ono HA, Oshima T, Fujii S, Takagawa R, Kimura J, Tokuhisa M, Izumisawa Y, Makino H, Akiyama H, Endo I. Significance of Thoracoscopy-Assisted Surgery with a Minithoracotomy and Hand-Assisted Laparoscopic Surgery for Esophageal Cancer: The Experience of a Single Surgeon. J Gastrointest Surg 2011;15:1939-51. [DOI: 10.1007/s11605-011-1664-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
272 Ludeman L, Shepherd NA. Pathological evaluation and implications of serosal involvement in gastrointestinal cancer. Recent Results Cancer Res 2007;169:25-38. [PMID: 17506247 DOI: 10.1007/978-3-540-30760-0_3] [Reference Citation Analysis]
273 Junginger T, Dutkowski P. Selective approach to the treatment of oesophageal cancer. British Journal of Surgery 1996;83:1473-7. [DOI: 10.1002/bjs.1800831047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
274 Hulscher JB, Van Sandick JW, Offerhaus GJ, Tilanus HW, Obertop H, Van Lanschot JJ. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the oesophagus or gastric cardia. Br J Surg. 2001;88:715-719. [PMID: 11350447 DOI: 10.1046/j.1365-2168.2001.01746.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
275 Shang QX, Chen LQ, Hu WP, Deng HY, Yuan Y, Cai J. Three-field lymph node dissection in treating the esophageal cancer. J Thorac Dis 2016;8:E1136-49. [PMID: 27867579 DOI: 10.21037/jtd.2016.10.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
276 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M, Doki Y. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol 2011;18:3353-61. [PMID: 21537861 DOI: 10.1245/s10434-011-1747-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
277 Jang HJ, Lee HS, Kim MS, Lee JM, Zo JI. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg 2011;92:1091-7. [PMID: 21704967 DOI: 10.1016/j.athoracsur.2011.03.093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
278 Xu HY, Wu SX, Luo HS, Chen CY, Lin LX, Huang HC. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis. Radiat Oncol 2018;13:200. [PMID: 30326912 DOI: 10.1186/s13014-018-1145-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
279 Nakamura M, Iwahashi M, Nakamori M, Ishida K, Naka T, Iida T, Katsuda M, Tsuji T, Nakatani Y, Yamaue H. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg 2008;393:127-33. [PMID: 18071746 DOI: 10.1007/s00423-007-0253-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
280 Teng S, Karl R. Surgical Approaches to Esophageal Cancer: The optimal surgical treatment approach for esophageal cancer remains controversial. Cancer Control 1999;6:36-42. [DOI: 10.1177/107327489900600103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Yajima K, Kosugi S, Kanda T, Matsuki A, Hatakeyama K. Risk factors of reflux esophagitis in the cervical remnant following esophagectomy with gastric tube reconstruction. World J Surg 2009;33:284-9. [PMID: 19083053 DOI: 10.1007/s00268-008-9856-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
282 Miyasaka D, Okushiba S, Sasaki T, Ebihara Y, Kawada M, Kawarada Y, Kitashiro S, Katoh H, Miyamoto M, Shichinohe T, Hirano S. Clinical evaluation of the feasibility of minimally invasive surgery in esophageal cancer. Asian J Endosc Surg 2013;6:26-32. [PMID: 23116427 DOI: 10.1111/j.1758-5910.2012.00158.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
283 Tanaka E, Okabe H, Tsunoda S, Obama K, Kan T, Kadokawa Y, Akagami M, Sakai Y. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy. Asian J Endosc Surg 2012;5:111-7. [PMID: 22776501 DOI: 10.1111/j.1758-5910.2012.00131.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
284 Shimada H, Matsubara H, Okazumi S, Isono K, Ochiai T. Improved Surgical Results in Thoracic Esophageal Squamous Cell Carcinoma: A 40-year Analysis of 792 Patients. J Gastrointest Surg 2008;12:518-26. [DOI: 10.1007/s11605-007-0280-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
285 Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis 2017;9:S713-23. [PMID: 28815067 DOI: 10.21037/jtd.2017.07.42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
286 Shimada H, Okazumi S, Shiratori T, Akutsu Y, Matsubara H. Mode of lymphadenectomy and surgical outcome of upper thoracic esophageal squamous cell carcinoma. J Gastrointest Surg. 2009;13:619-625. [PMID: 19156473 DOI: 10.1007/s11605-008-0790-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
287 Park SY, Kim DJ, Do YW, Suh J, Lee S. The Oncologic Outcome of Esophageal Squamous Cell Carcinoma Patients After Robot-Assisted Thoracoscopic Esophagectomy With Total Mediastinal Lymphadenectomy. The Annals of Thoracic Surgery 2017;103:1151-7. [DOI: 10.1016/j.athoracsur.2016.09.037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
288 Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Uenosono Y, Ishigami S, Owaki T, Aikou T. The role of salvage surgery for recurrence of esophageal squamous cell cancer. Eur J Surg Oncol. 2006;32:544-547. [PMID: 16567077 DOI: 10.1016/j.ejso.2006.02.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
289 Tong D, Law S. Extended Lymphadenectomy in Esophageal Cancer is Crucial. World J Surg 2013;37:1751-6. [DOI: 10.1007/s00268-013-2068-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
290 Zhang X, Chen SB, Chen JX, Wen J, Yang H, Xie MR, Zhang Y, Hu YZ, Lin P. CK19 mRNA expression in the bone marrow of patients with esophageal squamous cell carcinoma and its clinical significance. Dis Esophagus 2010;23:437-43. [PMID: 20095997 DOI: 10.1111/j.1442-2050.2009.01033.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
291 Stockeld D, Tennvall J, Wagenius G, Albertsson M, Backman L, Brodin O, Cwikiel M, Granström L, Gustafsson G, Gustavsson S, Hambraeus G, Lewensohn R, Sjöstedt S, Strander H, Âberg B, Fagerberg J. A Swedish Study of Chemoradiation in Squamous Cell Carcinoma of the Esophagus. Acta Oncologica 2009;40:566-73. [DOI: 10.1080/028418601750444097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
292 Jo YY, Yu J, Song KJ, Jang JY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study. Radiother Oncol 2021;162:112-8. [PMID: 34265356 DOI: 10.1016/j.radonc.2021.07.006] [Reference Citation Analysis]
293 Yao F, Wang J, Yao J, Xu L, Qian J, Cao Y. Is thoracoscopic-laparoscopic esophagectomy a better alternative to thoracoscopic esophagectomy? Int J Surg 2017;48:105-9. [PMID: 29061388 DOI: 10.1016/j.ijsu.2017.10.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
294 Shen Y, Zhang Y, Tan L, Feng M, Wang H, Khan MA, Liang M, Wang Q. Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. J Gastrointest Surg 2012;16:715-21. [PMID: 22258878 DOI: 10.1007/s11605-012-1824-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
295 Yang J, Zhang W, Xiao Z, Wang Q, Zhou Z, Zhang H, Chen D, Feng Q, He J, Gao S, Sun K, Liu X, Fang D, Mu J, Wang D, Li Y. The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis. J Thorac Oncol. 2017;12:1143-1151. [PMID: 28411098 DOI: 10.1016/j.jtho.2017.03.024] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
296 Ninomiya I, Osugi H, Tomizawa N, Fujimura T, Kayahara M, Takamura H, Fushida S, Oyama K, Nakagawara H, Makino I, Ohta T. Learning of thoracoscopic radical esophagectomy: how can the learning curve be made short and flat?: Learning of thoracoscopic esophagectomy. Diseases of the Esophagus 2010;23:618-26. [DOI: 10.1111/j.1442-2050.2010.01075.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
297 Takeuchi H, Kawakubo H, Kitagawa Y. Current status of minimally invasive esophagectomy for patients with esophageal cancer. Gen Thorac Cardiovasc Surg. 2013;61:513-521. [PMID: 23661109 DOI: 10.1007/s11748-013-0258-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
298 Takeno S, Takahashi Y, Moroga T, Kawahara K, Yamashita Y, Ohtaki M. Retrospective study using the propensity score to clarify the oncologic feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg 2013;37:1673-80. [PMID: 23539192 DOI: 10.1007/s00268-013-2008-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
299 Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, Nakagawa K. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiat Oncol 2015;10:171. [PMID: 26269033 DOI: 10.1186/s13014-015-0482-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
300 Gardner B. Eat your cereal. Annals of Surgical Oncology 1996;3:1-7. [DOI: 10.1007/bf02409044] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
301 Siewert J, Stein H, Fink U. Multimodality Therapy for Esophageal Cancer. The Oncologist 1996;1:210-8. [DOI: 10.1634/theoncologist.1-4-210] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
302 Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 2021;273:751-7. [PMID: 31188215 DOI: 10.1097/SLA.0000000000003383] [Reference Citation Analysis]
303 Wong I, Tong DKH, Tsang RKY, Wong CLY, Chan DKK, Chan FSY, Law S. Continuous intraoperative vagus nerve stimulation for monitoring of recurrent laryngeal nerve during minimally invasive esophagectomy. J Vis Surg 2017;3:9. [PMID: 29078572 DOI: 10.21037/jovs.2016.12.11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
304 Maruyama T, Mimura K, Sato E, Watanabe M, Mizukami Y, Kawaguchi Y, Ando T, Kinouchi H, Fujii H, Kono K. Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma. Br J Cancer 2010;103:552-9. [PMID: 20628381 DOI: 10.1038/sj.bjc.6605772] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
305 van Sandick JW, van Lanschot JB, ten Kate FJ, Tijssen JG, Obertop H. Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer1 1No competing interests declared. Journal of the American College of Surgeons 2002;194:28-36. [DOI: 10.1016/s1072-7515(01)01119-x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
306 Suzuki S, Nishimaki T, Suzuki T, Kanda T, Nakagawa S, Hatakeyama K. Outcomes of simultaneous resection of synchronous esophageal and extraesophageal carcinomas. J Am Coll Surg. 2002;195:23-29. [PMID: 12113541 DOI: 10.1016/s1072-7515(02)01147-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
307 Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005;104:1349-55. [PMID: 16130133 DOI: 10.1002/cncr.21346] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 4.9] [Reference Citation Analysis]
308 Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Asahara T, Nomoto K, Ishikawa O. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial. Surgery 2012;152:832-42. [DOI: 10.1016/j.surg.2012.02.021] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
309 Itami A, Watanabe G, Tanaka E, Nakayama S, Fujimoto A, Kondo M, Nakau M, Okabe H, Satoh S, Sakai Y. Upper mediastinal lymph node dissection for esophageal cancer through a thoracoscopic approach. Surg Endosc 2008;22:2741-2741. [DOI: 10.1007/s00464-008-0106-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
310 Makino T, Yamasaki M, Miyata H, Tanaka K, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Solitary Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: Surgical Failure or Systemic Disease? Ann Surg Oncol 2016;23:2087-93. [DOI: 10.1245/s10434-015-5086-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
311 Ganesamoni S, Krishnamurthy A. Three-field transthoracic versus transhiatal esophagectomy in the management of carcinoma esophagus-a single--center experience with a review of literature. J Gastrointest Cancer 2014;45:66-73. [PMID: 24272910 DOI: 10.1007/s12029-013-9562-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
312 Otsubo D, Nakamura T, Yamamoto M, Kanaji S, Kanemitsu K, Yamashita K, Imanishi T, Oshikiri T, Sumi Y, Suzuki S, Kuroda D, Kakeji Y. Prone position in thoracoscopic esophagectomy improves postoperative oxygenation and reduces pulmonary complications. Surg Endosc 2017;31:1136-41. [PMID: 27387180 DOI: 10.1007/s00464-016-5081-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
313 Chen YJ, Schultheiss TE, Wong JY, Kernstine KH. Impact of the number of resected and involved lymph nodes on esophageal cancer survival. J Surg Oncol 2009;100:127-32. [PMID: 19544364 DOI: 10.1002/jso.21312] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
314 Chai T, Shen Z, Chen S, Lin Y, Zhang Z, Lin W, Hong J, Yang C, Kang M, Lin J. Right versus left thoracic approach oesophagectomy for oesophageal cancer: a systematic review and meta-analysis protocol. BMJ Open 2019;9:e030157. [PMID: 31289096 DOI: 10.1136/bmjopen-2019-030157] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Kato K, Tahara M, Hironaka S, Muro K, Takiuchi H, Hamamoto Y, Imamoto H, Amano N, Seriu T. A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol. 2011;67:1265-1272. [PMID: 20703479 DOI: 10.1007/s00280-010-1422-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 5.2] [Reference Citation Analysis]
316 Motoyama S, Maruyama K, Sato Y, Usami S, Nakatsu T, Saito H, Minamiya Y, Ogawa J. Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and t2-4 thoracic squamous cell esophageal cancers. World J Surg 2009;33:512-7. [PMID: 19009319 DOI: 10.1007/s00268-008-9781-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
317 Fujii H, Kitagawa Y, Kitajima M, Kubo A. Sentinel nodes of malignancies originating in the alimentary tract. Ann Nucl Med. 2004;18:1-12. [PMID: 15072178 DOI: 10.1007/bf02985608] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
318 Zheng Y, Wang Z, Wang F, Huang Q, Liu S. Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification. Oncotarget 2017;8:41563-71. [PMID: 28147340 DOI: 10.18632/oncotarget.14892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
319 Kitagawa Y, Kitajima M. Gastroesophageal carcinoma: individualized surgical therapy. Surg Oncol Clin N Am 2006;15:793-802. [PMID: 17030274 DOI: 10.1016/j.soc.2006.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
320 Motoori M, Yano M, Yasuda T, Miyata H, Peng Y, Yamasaki M, Shiraishi O, Tanaka K, Ishikawa O, Shiozaki H, Doki Y. Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapy. Mol Clin Oncol 2013;1:521-6. [PMID: 24649204 DOI: 10.3892/mco.2013.89] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
321 Martins AS. Neck and mediastinal node dissection in pharyngolaryngoesophageal tumors. Head Neck. 2001;23:772-779. [PMID: 11505488 DOI: 10.1002/hed.1110] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
322 Tong Z, Yang X, Luo F, Zhu J, Kang M, Lin J. Application of neck anastomotic muscle flap embedded in 3-incision radical resection of oesophageal carcinoma: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2020;99:e22263. [PMID: 33031267 DOI: 10.1097/MD.0000000000022263] [Reference Citation Analysis]
323 Ojima T, Nakamori M, Nakamura M, Katsuda M, Hayata K, Matsumura S, Iwahashi M, Yamaue H. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus. Dis Esophagus 2017;30:1-7. [PMID: 26725778 DOI: 10.1111/dote.12450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
324 O'Riordan JM, Rowley S, Murphy JO, Ravi N, Byrne PJ, Reynolds JV. Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction. J Gastrointest Surg 2007;11:493-9. [PMID: 17436135 DOI: 10.1007/s11605-006-0027-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
325 Li H, Yang S, Zhang Y, Xiang J, Chen H. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma. J Surg Oncol. 2012;105:548-552. [PMID: 22105736 DOI: 10.1002/jso.22148] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
326 Demeester TR. SURGICAL TREATMENT OF DYSPLASIA AND ADENOCARCINOMA. Gastroenterology Clinics of North America 1997;26:669-84. [DOI: 10.1016/s0889-8553(05)70321-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
327 Hirano S, Nagahara K, Moritani S, Kitamura M, Takagita S. Upper Mediastinal Node Dissection for Hypopharyngeal and Cervical Esophageal Carcinomas. Ann Otol Rhinol Laryngol 2007;116:290-6. [DOI: 10.1177/000348940711600413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
328 Hsu C, Chen C, Hsia J, Shai S. Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus. European Journal of Cardio-Thoracic Surgery 2001;19:10-3. [DOI: 10.1016/s1010-7940(00)00623-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
329 Ma MW, Gao XS, Gu XB, Xie M, Cui M, Zhang M, Liu L, Yin H, Chen LQ. The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma. World J Surg Oncol 2018;16:172. [PMID: 30119684 DOI: 10.1186/s12957-018-1470-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
330 Iyer R, Wilkinson N, Demmy T, Javle M. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 2004;11:665-73. [PMID: 15197012 DOI: 10.1245/ASO.2004.10.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
331 Tabira Y, Okuma T, Kondo K, Kitamura N. Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. The Journal of Thoracic and Cardiovascular Surgery 1999;117:239-45. [DOI: 10.1016/s0022-5223(99)70418-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
332 Sato S, Nagai E, Taki Y, Watanabe M, Watanabe Y, Nakano K, Yamada H, Chiba T, Ishii Y, Ogiso H, Takagi M. Hand grip strength as a predictor of postoperative complications in esophageal cancer patients undergoing esophagectomy. Esophagus 2018;15:10-8. [PMID: 29892804 DOI: 10.1007/s10388-017-0587-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
333 Takeuchi H, Miyata H, Gotoh M, Kitagawa Y, Baba H, Kimura W, Tomita N, Nakagoe T, Shimada M, Sugihara K, Mori M. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259-266. [PMID: 24743609 DOI: 10.1097/sla.0000000000000644] [Cited by in Crossref: 275] [Cited by in F6Publishing: 111] [Article Influence: 39.3] [Reference Citation Analysis]
334 Farrokhnia F, Makarem J, Khan ZH, Mohagheghi M, Maghsoudlou M, Abdollahi A. The Effects of Prostaglandin E 1 on Interleukin-6, Pulmonary Function and Postoperative Recovery in Oesophageetomised Patients. Anaesth Intensive Care 2009;37:937-43. [DOI: 10.1177/0310057x0903700618] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
335 Demeester TR. Esophageal carcinoma: Current controversies. Semin Surg Oncol 1997;13:217-33. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<217::aid-ssu2>3.0.co;2-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
336 Shimada H, Okazumi S, Matsubara H, Shiratori T, Shuto K, Akutsu Y, Nabeya Y, Hayashi H, Ochiai T. Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinoma. The American Journal of Surgery 2007;193:448-52. [DOI: 10.1016/j.amjsurg.2006.06.047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
337 Huang YC, Chen TW, Zhang XM, Zeng NL, Li R, Tang YL, Chen F, Chen YL. Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage. Br J Radiol 2018;91:20170421. [PMID: 29308923 DOI: 10.1259/bjr.20170421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
338 Leong SPL, Cady B, Jablons DM, Garcia-aguilar J, Reintgen D, Werner JA, Kitagawa Y. Patterns of Metastasis in Human Solid Cancers. In: Leong SPL, editor. Cancer Metastasis And The Lymphovascular System: Basis For Rational Therapy. Boston: Springer US; 2007. pp. 209-21. [DOI: 10.1007/978-0-387-69219-7_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
339 Nagaraja V, Eslick GD, Cox MR. Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysis. J Gastrointest Oncol 2014;5:127-41. [PMID: 24772341 DOI: 10.3978/j.issn.2078-6891.2014.008] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
340 Yano M, Yasuda T, Miyata H, Fujiwara Y, Takiguchi S, Monden M. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus. J Surg Oncol 2005;89:244-50. [DOI: 10.1002/jso.20209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
341 Pai CP, Hsu PK, Chien LI, Huang CS, Hsu HS. Clinical outcome of patients after recurrent laryngeal nerve lymph node dissection for oesophageal squamous cell carcinoma. Interact Cardiovasc Thorac Surg 2021:ivab293. [PMID: 34734236 DOI: 10.1093/icvts/ivab293] [Reference Citation Analysis]
342 Daiko H, Fujita T. Laparoscopic assisted versus open gastric pull-up following thoracoscopic esophagectomy: A cohort study. Int J Surg 2015;19:61-6. [PMID: 25986060 DOI: 10.1016/j.ijsu.2015.04.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
343 Mine S, Watanabe M, Kumagai K, Okamura A, Yuda M, Hayami M, Yamashita K, Imamura Y, Ishizuka N. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction. Dis Esophagus 2019;32:doz002. [PMID: 30791046 DOI: 10.1093/dote/doz002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
344 Wu J, Chai Y, Zhou XM, Chen QX, Yan FL. Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus. World J Gastroenterol 2008; 14(32): 5084-5089 [PMID: 18763294 DOI: 10.3748/wjg.14.5084] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
345 Raja S, Luketich JD, Kelly LA, Gooding WE, Finkelstein SD, Godfrey TE. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg. 2002;123:475-482. [PMID: 11882818 DOI: 10.1067/mtc.2002.119884] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
346 Noshiro H, Yoda Y, Hiraki M, Kono H, Miyake S, Uchiyama A, Nagai E. Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy. Dis Esophagus 2016;29:1090-9. [PMID: 26541471 DOI: 10.1111/dote.12426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
347 Tangoku A, Yoshino S, Abe T, Morita K, Ueno T, Hayashi H, Oka M. Mediastinoscopy-Assisted Transhiatal Esophagectomy: A Safe Technique for Squamous Cell Carcinoma of the Esophagus. In: Imamura M, editor. Superficial Esophageal Neoplasm. Tokyo: Springer Japan; 2002. pp. 225-35. [DOI: 10.1007/978-4-431-67873-1_29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
348 Yano M, Takachi K, Doki Y, Miyashiro I, Kishi K, Noura S, Eguchi H, Yamada T, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Matsunaga T, Imaoka S. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer. Dis Esophagus 2006;19:73-7. [PMID: 16643173 DOI: 10.1111/j.1442-2050.2006.00543.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
349 Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z, Liu X. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol. 2010;95:229-233. [PMID: 20189259 DOI: 10.1016/j.radonc.2010.01.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
350 Qubain SW, Natsugoe S, Matsumoto M, Nakashima S, Baba M, Takao S, Aikou T. Micrometastases in the cervical lymph nodes in esophageal squamous cell carcinoma. Diseases of the Esophagus 2001;14:143-8. [DOI: 10.1046/j.1442-2050.2001.00173.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
351 Teyton P, Metges JP, Atmani A, Jestin-Le Tallec V, Volant A, Visvikis D, Bail JP, Pradier O, Lozac'h P, Cheze Le Rest C. Use of positron emission tomography in surgery follow-up of esophageal cancer. J Gastrointest Surg. 2009;13:451-458. [PMID: 19023632 DOI: 10.1007/s11605-008-0749-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
352 Shimada Y, Imamura M, Sato F, Maeda M, Kaganoi J, Hashimoto Y, Kan T, Nagatani S, Li Z. Indications for abdominal para-aortic lymph node dissection in patients with esophageal squamous cell carcinoma. Surgery 2002;132:93-9. [PMID: 12110801 DOI: 10.1067/msy.2002.125486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
353 Tong DK, Law S. Management of oesophageal cancer. Indian J Surg 2009;71:317-25. [PMID: 23133184 DOI: 10.1007/s12262-009-0087-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
354 Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 2006;19:152-7. [PMID: 16722991 DOI: 10.1111/j.1442-2050.2006.00557.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
355 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109. [PMID: 15701501 DOI: 10.1016/j.amjsurg.2004.10.001] [Cited by in Crossref: 118] [Cited by in F6Publishing: 120] [Article Influence: 6.9] [Reference Citation Analysis]
356 Rao YG, Pal S, Pande GK, Sahni P, Chattopadhyay TK. Transhiatal esophagectomy for benign and malignant conditions. Am J Surg 2002;184:136-42. [PMID: 12169357 DOI: 10.1016/s0002-9610(02)00906-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
357 Bona D, Lombardo F, Matsushima K, Cavalli M, Lastraioli C, Bonitta G, Cirri S, Danelli P, Aiolfi A. Three-field versus two-field lymphadenectomy for esophageal squamous cell carcinoma: A long-term survival meta-analysis. Surgery 2021:S0039-6060(21)00844-8. [PMID: 34544603 DOI: 10.1016/j.surg.2021.08.029] [Reference Citation Analysis]
358 Watanabe M, Kuwano H, Araki K, Kawaguchi H, Saeki H, Kitamura K, Ohno S, Sugimachi K. Prognostic factors in patients with submucosal carcinoma of the oesophagus. Br J Cancer 2000;83:609-13. [PMID: 10944600 DOI: 10.1054/bjoc.2000.1288] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
359 Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer. 2003;97:1616-1623. [PMID: 12655517 DOI: 10.1002/cncr.11228] [Cited by in Crossref: 258] [Cited by in F6Publishing: 243] [Article Influence: 13.6] [Reference Citation Analysis]
360 Puli SR, Reddy JB, Bechtold ML, Antillon MR, Ibdah JA. Accuracy of endoscopic ultrasound in the diagnosis of distal and celiac axis lymph node metastasis in esophageal cancer: a meta-analysis and systematic review. Dig Dis Sci. 2008;53:2405-2414. [PMID: 18097752 DOI: 10.1007/s10620-007-0152-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
361 Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology. 2005;47:123-131. [PMID: 16045772 DOI: 10.1111/j.1365-2559.2005.02189.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 3.3] [Reference Citation Analysis]
362 Ninomiya I, Osugi H, Fujimura T, Kayahara M, Takamura H, Takemura M, Lee S, Nakagawara H, Nishimura G, Ohta T. Results of video-assisted thoracoscopic surgery for esophageal cancer during the induction period. Gen Thorac Cardiovasc Surg 2008;56:119-25. [PMID: 18340511 DOI: 10.1007/s11748-007-0196-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
363 Li B, Yang Y, Toker A, Yu B, Kang CH, Abbas G, Soukiasian HJ, Li H, Daiko H, Jiang H, Fu J, Yi J, Kernstine K, Migliore M, Bouvet M, Ricciardi S, Chao YK, Kim YH, Wang Y, Yu Z, Abbas AE, Sarkaria IS, Li Z; Cooperative Group of International Expert Consensus on Robot-assisted Esophagectomy for Esophageal Cancer. International consensus statement on robot-assisted minimally invasive esophagectomy (RAMIE). J Thorac Dis 2020;12:7387-401. [PMID: 33447428 DOI: 10.21037/jtd-20-1945] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
364 Lerut T. Is there a role for radical esophagectomy*1. European Journal of Cardio-Thoracic Surgery 1999;16:S44-7. [DOI: 10.1016/s1010-7940(99)00185-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
365 Imano H, Motoyama S, Saito R, Minamiya Y, Katayose Y, Okuyama M, Nakamura M, Ishiyama K, Sashi R, Ogawa J. Superior mediastinal and neck lymphatic mapping in mid- and lower-thoracic esophageal cancer as defined by ferumoxides-enhanced magnetic resonance imaging. Jpn J Thorac Caridovasc Surg 2004;52:445-50. [DOI: 10.1007/s11748-004-0137-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
366 Doki Y, Ishikawa O, Mano M, Hiratsuka M, Sasaki Y, Kameyama M, Ohigashi H, Murata K, Yamada T, Miyashiro I, Yokoyama S, Ishiguro S, Imaoka S. Cytokeratin deposits in lymph nodes show distinct clinical significance from lymph node micrometastasis in human esophageal cancers. J Surg Res 2002;107:75-81. [PMID: 12384067 DOI: 10.1006/jsre.2002.6506] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
367 Yamashita K, Makino T, Yamasaki M, Tanaka K, Hara T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer. Dis Esophagus 2017;30:1-8. [PMID: 28881906 DOI: 10.1093/dote/dox096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
368 Tan Z, Chen Y, Ma G, Meng Y, Fu J, Zhang L, Long H, Rong T, Lin P. Validation of the 7th edition American Joint Committee on cancer staging system for esophageal squamous cell carcinoma. Thorac Cancer 2013;4:410-5. [PMID: 28920222 DOI: 10.1111/1759-7714.12039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
369 Matsumoto S, Takayama T, Wakatsuki K, Enomoto K, Tanaka T, Migita K, Ito M, Nakajima Y. Predicting Early Cancer-related Deaths after Curative Esophagectomy for Esophageal Cancer. The American Surgeon 2013;79:528-33. [DOI: 10.1177/000313481307900530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
370 Kawaguchi Y, Kono K, Mimura K, Sugai H, Akaike H, Fujii H. Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma. Int J Cancer. 2007;120:781-787. [PMID: 17096332 DOI: 10.1002/ijc.22370] [Cited by in Crossref: 122] [Cited by in F6Publishing: 106] [Article Influence: 8.1] [Reference Citation Analysis]
371 Kono K, Sugai H, Omata H, Fujii H. Transient Bloodletting of the Short Gastric Vein in the Reconstructed Gastric Tube Improves Gastric Microcirculation During Esophagectomy. World J Surg 2007;31:780-4. [DOI: 10.1007/s00268-006-0285-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
372 Ji X, Cai J, Chen Y, Chen LQ. Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg 2016; 8(1): 90-94 [PMID: 26843917 DOI: 10.4240/wjgs.v8.i1.90] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
373 Piessen G, Mariette C, Triboulet JP. [Cervical and upper-third thoracic oesophageal carcinoma: a single pathological entity?]. Ann Chir 2005;130:86-91. [PMID: 15737319 DOI: 10.1016/j.anchir.2004.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
374 Torres JE, Tsoulfas G, Hamdy K, Scott-conner CE. Laparoscopic surgery for the prevention, palliation, and cure of gastrointestinal malignancies. Medical Clinics of North America 2005;89:187-209. [DOI: 10.1016/j.mcna.2004.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
375 Ninomiya I, Makino I, Fujimura T, Fushida S, Oyama K, Kinoshita J, Tajima H, Kitagawa H, Ohta T. Feeding catheter gastrostomy at esophagectomy with gastric tube reconstruction through posterior mediastinal route. Esophagus 2011;8:217-23. [DOI: 10.1007/s10388-011-0278-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Supraclavicular node metastasis from thoracic esophageal carcinoma: A surgical series from a Japanese multi-institutional nationwide registry of esophageal cancer. J Thorac Cardiovasc Surg 2014;148:1224-9. [PMID: 24613171 DOI: 10.1016/j.jtcvs.2014.02.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
377 Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg. 2000;232:225-232. [PMID: 10903602 DOI: 10.1097/00000658-200008000-00013] [Cited by in Crossref: 389] [Cited by in F6Publishing: 345] [Article Influence: 17.7] [Reference Citation Analysis]
378 Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893-906. [PMID: 16997168 DOI: 10.1016/j.bpg.2006.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
379 Kunisaki C, Makino H, Takagawa R, Yamamoto N, Nagano Y, Fujii S, Kosaka T, Ono HA, Otsuka Y, Akiyama H, Ichikawa Y, Shimada H. Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy. J Gastrointest Surg 2008;12:802-10. [PMID: 17952515 DOI: 10.1007/s11605-007-0385-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
380 Liu F, Wang W, Wang C, Peng X. Enhanced recovery after surgery (ERAS) programs for esophagectomy protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e0016. [PMID: 29465538 DOI: 10.1097/MD.0000000000010016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
381 Li H, Zhang ZR. Current status and future direction of lymph node dissection in radical surgery for esophageal cancer. J Thorac Dis 2019;11:S1678-82. [PMID: 31516741 DOI: 10.21037/jtd.2019.05.51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
382 Collard J. Exclusive radical surgery for esophageal adenocarcinoma. Cancer 2001;91:1098-104. [DOI: 10.1002/1097-0142(20010315)91:6<1098::aid-cncr1105>3.0.co;2-n] [Cited by in Crossref: 44] [Article Influence: 2.1] [Reference Citation Analysis]
383 Yekebas EF, Schurr PG, Kaifi JT, Link BC, Kutup A, Mann O, Wolfram L, Izbicki JR. Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases. J Surg Oncol 2006;93:541-9. [PMID: 16705730 DOI: 10.1002/jso.20544] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
384 Iwahashi M, Katsuda M, Nakamori M, Nakamura M, Naka T, Ojima T, Iida T, Yamaue H. Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T cell response in patients with metastatic esophageal squamous cell carcinoma. Cancer Sci 2010;101:2510-7. [PMID: 20874827 DOI: 10.1111/j.1349-7006.2010.01732.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
385 Luo KJ, Hu Y, Wen J, Fu JH. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol. 2011;104:236-243. [PMID: 21480261 DOI: 10.1002/jso.21921] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
386 Trung LV, Loc NVV, Tien TPD, Ai BD, Lam TLQ, Vuong NL. Robot-Assisted Versus Thoraco-laparoscopic McKeown Esophagectomy for Esophageal Cancer: a Propensity Score-Matched Study. J Gastrointest Surg 2021. [PMID: 34786664 DOI: 10.1007/s11605-021-05200-0] [Reference Citation Analysis]
387 Nafteux PR, Lerut AM, Moons J, Hölscher AH, Bollschweiler E, van Berge Henegouwen MI, Lagarde SM, van Lanschot JJ, Messager M, Mariette C, D'Journo XB, Thomas PA, De Leyn PR. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems. Ann Surg 2015;262:809-15; discussion 815-6. [PMID: 26583670 DOI: 10.1097/SLA.0000000000001463] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
388 Sakurai Y, Masui T, Yoshida I, Tonomura S, Shoji M, Nakamura Y, Isogaki J, Uyama I, Komori Y, Ochiai M. Randomized Clinical Trial of the Effects of Perioperative Use of Immune-enhancing Enteral Formula on Metabolic and Immunological Status in Patients Undergoing Esophagectomy. World J Surg 2007;31:2150-7. [DOI: 10.1007/s00268-007-9170-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
389 Kaburagi T, Takeuchi H, Kawakubo H, Omori T, Ozawa S, Kitagawa Y. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg 2014;38:410-8. [PMID: 24101023 DOI: 10.1007/s00268-013-2258-4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
390 Hiranyatheb P, Osugi H. Radical lymphadenectomy in esophageal cancer: from the past to the present. Dis Esophagus. 2013;Jun 24; Epub ahead of print. [PMID: 23796327 DOI: 10.1111/dote.12091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
391 Samee A, Moorthy K, Jaipersad T, Crisp W, Cheruvu C, Elder J, Deakin M. Evaluation of the role of laparoscopic ultrasonography in the staging of oesophagogastric cancers. Surg Endosc 2009;23:2061-5. [PMID: 18548310 DOI: 10.1007/s00464-008-9968-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
392 Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol. 1998;9:951-962. [PMID: 9818067 DOI: 10.1023/A:1008273110272] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
393 Morita M, Maehara Y. Esophagus Carcinoma Surveillance Counterpoint: Japan. In: Johnson FE, Maehara Y, Browman GP, Margenthaler JA, Audisio RA, Thompson JF, Johnson DY, Earle CC, Virgo KS, editors. Patient Surveillance After Cancer Treatment. Totowa: Humana Press; 2013. pp. 101-5. [DOI: 10.1007/978-1-60327-969-7_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
394 Anbai A, Koga M, Motoyama S, Jin M, Shibata H, Hashimoto M. Outcomes of patients with stage IVA esophageal cancer (Japanese classification) treated with definitive chemoradiotherapy. Jpn J Radiol 2013;31:270-6. [DOI: 10.1007/s11604-013-0180-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
395 Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234:360-7; discussion 368. [PMID: 11524589 DOI: 10.1097/00000658-200109000-00010] [Cited by in Crossref: 367] [Cited by in F6Publishing: 320] [Article Influence: 17.5] [Reference Citation Analysis]
396 Sonohara F, Gao F, Iwata N, Kanda M, Koike M, Takahashi N, Yamada Y, Kodera Y, Wang X, Goel A. Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Ann Surg 2019;269:879-86. [PMID: 29240008 DOI: 10.1097/SLA.0000000000002622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
397 Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, Makuuchi H, Tanaka O, Yamana H, Ikeuchi S, Kabuto T, Nagai K, Shimada Y, Kinjo Y, Fukuda H; Japan Clinical Oncology Group. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol. 2003;21:4592-4596. [PMID: 14673047 DOI: 10.1200/jco.2003.12.095] [Cited by in Crossref: 455] [Cited by in F6Publishing: 179] [Article Influence: 25.3] [Reference Citation Analysis]
398 Collard JM, Otte JB, Fiasse R, Laterre PF, De Kock M, Longueville J, Glineur D, Romagnoli R, Reynaert M, Kestens PJ. Skeletonizing en bloc esophagectomy for cancer. Ann Surg 2001;234:25-32. [PMID: 11420480 DOI: 10.1097/00000658-200107000-00005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 3.6] [Reference Citation Analysis]
399 Ye B, Zhong CX, Yang Y, Fang WT, Mao T, Ji CY, Li ZG. Lymph node dissection in esophageal carcinoma: Minimally invasive esophagectomy vs open surgery. World J Gastroenterol 2016; 22(19): 4750-4756 [PMID: 27217706 DOI: 10.3748/wjg.v22.i19.4750] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
400 Sasikumar K, Kalayarasan R, Gnanasekaran S, Chandrasekar S, Pottakkat B. Minimally invasive oesophagectomy with a total two-field lymphadenectomy after neoadjuvant chemoradiotherapy for locally advanced squamous cell carcinoma of the oesophagus: A prospective study. J Minim Access Surg 2021;17:49-55. [PMID: 31929228 DOI: 10.4103/jmas.JMAS_242_19] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Kodaira T, Fuwa N, Itoh Y, Kamata M, Furutani K, Hatooka S, Shinoda M. Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy. Am J Clin Oncol 2003;26:392-7. [PMID: 12902893 DOI: 10.1097/01.COC.0000026910.23905.AA] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
402 Jing Z, Chen T, Zhang X, Wu S. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer. Cancer Sci 2017;108:1828-33. [PMID: 28665042 DOI: 10.1111/cas.13308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
403 Watanabe M, Nishida K, Kimura Y, Miyazaki M, Baba H. Salvage lymphadenectomy for cervical lymph node recurrence after esophagectomy for squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 2012;25:62-6. [PMID: 21676066 DOI: 10.1111/j.1442-2050.2011.01215.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
404 Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy for treatment of benign and malignant esophageal disease. World J Surg 2001;25:196-203. [PMID: 11338022 [PMID: 11338022 DOI: 10.1007/s002680020019] [Cited by in Crossref: 104] [Cited by in F6Publishing: 66] [Article Influence: 5.0] [Reference Citation Analysis]
405 Taniyama Y, Nakamura T, Mitamura A, Teshima J, Katsura K, Abe S, Nakano T, Kamei T, Miyata G, Ouchi N. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg. 2013;95:1930-1937. [PMID: 23642437 DOI: 10.1016/j.athoracsur.2013.03.069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
406 Wu J, Chen QX, Zhou XM, Mao WM, Krasna MJ. Does recurrent laryngeal nerve lymph node metastasis really affect the prognosis in node-positive patients with squamous cell carcinoma of the middle thoracic esophagus? BMC Surg 2014;14:43. [PMID: 25016483 DOI: 10.1186/1471-2482-14-43] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
407 Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, Hatakeyama K. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 2004;198:205-211. [PMID: 14759776 DOI: 10.1016/j.jamcollsurg.2003.10.005] [Cited by in Crossref: 209] [Cited by in F6Publishing: 220] [Article Influence: 11.6] [Reference Citation Analysis]
408 Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N. En-bloc esophagectomy for esophageal cancer. The American Journal of Surgery 2004;188:254-60. [DOI: 10.1016/j.amjsurg.2004.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
409 Mine S, Watanabe M. Reply to 'Is there really no difference of mediastinal lymph node metastasis pattern between esophageal adenocarcinoma and squamous cell carcinoma?'. Dis Esophagus 2019;32:doz044. [PMID: 31069377 DOI: 10.1093/dote/doz044] [Reference Citation Analysis]
410 Oshikiri T, Yamamoto Y, Miki I, Tsuda M, Nakamura T, Fujino Y, Tominaga M, Kakeji Y. Conservative reconstruction using stents as salvage therapy for disruption of esophago-gastric anastomosis. World J Gastroenterol 2015; 21(28): 8723-8729 [PMID: 26229414 DOI: 10.3748/wjg.v21.i28.8723] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
411 Kato F, Takeuchi H, Matsuda S, Kawakubo H, Omori T, Kitagawa Y. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study. Surg Today 2016;46:445-52. [DOI: 10.1007/s00595-015-1196-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
412 Zafirellis K, Dolan K, Fountoulakis A, Dexter SP, Martin IG, Sue-Ling HM. Multivariate analysis of clinical, operative and pathologic features of esophageal cancer: who needs adjuvant therapy? Dis Esophagus. 2002;15:155-159. [PMID: 12220424 DOI: 10.1046/j.1442-2050.2002.00230.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
413 Kranzfelder M, Büchler P, Lange K, Friess H. Treatment options for squamous cell cancer of the esophagus: a systematic review of the literature. J Am Coll Surg 2010;210:351-9. [PMID: 20193900 DOI: 10.1016/j.jamcollsurg.2009.12.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
414 Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N. Prognostic Significance of Perioperative Blood Transfusions in Resectable Thoracic Esophageal Cancer. American Journal of Gastroenterology 1999;94:757-65. [DOI: 10.1111/j.1572-0241.1999.00948.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
415 Law S, Wong J. Lymph node dissection in surgical treatment of esophageal neoplasms. Surg Oncol Clin N Am 2007;16:115-31. [PMID: 17336240 DOI: 10.1016/j.soc.2006.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
416 Depypere L, Van Veer H, Nafteux PR, Coosemans W, Lerut T. Options for Esophageal Replacement. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. Elsevier; 2019. pp. 438-66. [DOI: 10.1016/b978-0-323-40232-3.00041-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
417 Yannopoulos P, Theodoridis P, Manes K. Esophagectomy without thoracotomy: 25 years of experience over 750 patients. Langenbecks Arch Surg 2009;394:611-6. [PMID: 19350267 DOI: 10.1007/s00423-009-0488-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
418 Ishiyama K, Motoyama S, Tomura N, Sashi R, Imano H, Ogawa J, Narita K, Watarai J. Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J Comput Assist Tomogr 2006;30:270-5. [PMID: 16628046 DOI: 10.1097/00004728-200603000-00020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
419 Tachibana M, Dhar DK, Kinugasa S, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Nagasue N. Esophageal cancer with distant lymph node metastasis: prognostic significance of metastatic lymph node ratio. J Clin Gastroenterol 2000;31:318-22. [PMID: 11129274 DOI: 10.1097/00004836-200012000-00010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
420 Duong TT, An HH, Quoc LV, Truong NV, Son VN, Hien NV, Tuan NP, Sang NV, Duc NM. Outcomes of Right Thoracoscopic Esophagectomy Combined with Laparotomy: a Preliminary Vietnamese Study. Med Arch 2020;74:463-9. [PMID: 33603272 DOI: 10.5455/medarh.2020.74.463-469] [Reference Citation Analysis]
421 Natsugoe S, Matsumoto M, Okumura H, Uchikado Y, Setoyama T, Sasaki K, Sakurai T, Omoto I, Owaki T, Shinchi H. Clinical course and outcome after esophagectomy with three-field lymphadenectomy in esophageal cancer. Langenbecks Arch Surg. 2010;395:341-346. [PMID: 20361205 DOI: 10.1007/s00423-010-0592-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
422 Udagawa H, Ueno M, Kinoshita Y. Rationale for video-assisted radical esophagectomy. Gen Thorac Cardiovasc Surg 2009;57:127-31. [DOI: 10.1007/s11748-008-0362-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
423 Kumai Y, Miyamoto T, Matsubara K, Samejima Y, Yoshida N, Baba H, Orita Y. Determining the Efficacy of the Chin-Down Maneuver Following Esophagectomy With Fiberoptic Endoscopic Evaluation of Swallowing. Arch Phys Med Rehabil 2019;100:1076-84. [PMID: 30391411 DOI: 10.1016/j.apmr.2018.10.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
424 Vickers J, Alderson D. Oesophageal cancer staging using endoscopic ultrasonography. British Journal of Surgery 1998;85:994-8. [DOI: 10.1046/j.1365-2168.1998.00694.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
425 Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu T. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 2006;106:1017-25. [DOI: 10.1002/cncr.21693] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
426 Miyata H, Yamasaki M, Makino T, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y. Therapeutic value of lymph node dissection for esophageal squamous cell carcinoma after neoadjuvant chemotherapy. J Surg Oncol 2015;112:60-5. [PMID: 26179950 DOI: 10.1002/jso.23965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
427 Chadha KS, Hernandez-Ilizaliturri FJ, Javle M. Primary esophageal lymphoma: case series and review of the literature. Dig Dis Sci. 2006;51:77-83. [PMID: 16416216 DOI: 10.1007/s10620-006-3088-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
428 Cai W, Li Y, Huang B, Hu C. Esophageal cancer lymph node metastasis-associated gene signature optimizes overall survival prediction of esophageal cancer. J Cell Biochem 2019;120:592-600. [PMID: 30242875 DOI: 10.1002/jcb.27416] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
429 Wang J, Liu M, Shen J, Ouyang H, Xie X, Lin T, Li A, Yang H. Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer. BMC Cancer 2018;18:737. [PMID: 30005630 DOI: 10.1186/s12885-018-4643-8] [Reference Citation Analysis]
430 Schröder W, Mönig SP, Baldus SE, Gutschow C, Schneider PM, Hölscher AH. Frequency of nodal metastases to the upper mediastinum in Barrett's cancer. Ann Surg Oncol 2002;9:807-11. [PMID: 12374665 DOI: 10.1007/BF02574504] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
431 Shimada H, Shiratori T, Okazumi S, Matsubara H, Shuto K, Akutsu Y, Narushima K, Nabeya Y, Hayashi H, Ochiai T. Surgical Outcome of Elderly Patients 75 Years of Age and Older with Thoracic Esophageal Carcinoma. World J Surg 2007;31:773-9. [DOI: 10.1007/s00268-007-0606-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
432 Kang Y, Hwang Y, Lee HJ, Park IK, Kim YT, Kang CH. Patterns and Prognostic Significance of Cervical Lymph Node Metastasis and the Efficacy of Cervical Node Dissection in Esophageal Cancer. Korean J Thorac Cardiovasc Surg 2017;50:329-38. [PMID: 29124024 DOI: 10.5090/kjtcs.2017.50.5.329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
433 Fujita H. President's address of the 65th annual scientific meeting of the Japanese Association for Thoracic Surgery: challenges for advanced esophageal cancer. Gen Thorac Cardiovasc Surg 2013;61:201-7. [PMID: 23404311 DOI: 10.1007/s11748-013-0213-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
434 Motoori M, Ito Y, Miyashiro I, Sugimura K, Miyata H, Omori T, Fujiwara Y, Yano M. Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy. Oncology 2019;97:149-54. [DOI: 10.1159/000500604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
435 Scholtemeijer MG, Seesing MFJ, Brenkman HJF, Janssen LM, van Hillegersberg R, Ruurda JP. Recurrent laryngeal nerve injury after esophagectomy for esophageal cancer: incidence, management, and impact on short- and long-term outcomes. J Thorac Dis 2017;9:S868-78. [PMID: 28815085 DOI: 10.21037/jtd.2017.06.92] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
436 Thomas P, Acri P, Doddoli C, D'journo B, Trousse D, Michelet P, Chetaille B, Papazian L, Giovannini M, Seitz JF, Giudicelli R, Fuentes P. [Surgery for oesophageal cancer: current controversies]. Ann Chir 2003;128:351-8. [PMID: 12943829 DOI: 10.1016/s0003-3944(03)00122-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
437 Hulscher JB, Tijssen JG, Obertop H, van Lanschot JJ. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg. 2001;72:306-313. [PMID: 11465217 DOI: 10.1016/s0003-4975(00)02570-4] [Cited by in Crossref: 401] [Cited by in F6Publishing: 115] [Article Influence: 19.1] [Reference Citation Analysis]
438 Mine S, Udagawa H, Tsutsumi K, Kinoshita Y, Ueno M, Ehara K, Haruta S. Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg. 2009;88:1647-1653. [PMID: 19853126 DOI: 10.1016/j.athoracsur.2009.05.081] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
439 Koyanagi K, Ozawa S, Tachimori Y. Minimally invasive esophagectomy performed with the patient in a prone position: a systematic review. Surg Today 2016;46:275-84. [DOI: 10.1007/s00595-015-1164-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
440 Mimura K, Kono K, Hanawa M, Mitsui F, Sugai H, Miyagawa N, Ooi A, Fujii H. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma. Br J Cancer. 2005;92:1253-1260. [PMID: 15785739 DOI: 10.1038/sj.bjc.6602499] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 4.9] [Reference Citation Analysis]
441 Wang Z, Mao Y, Gao S, Li Y, Tan L, Daiko H, Liu S, Chen C, Koyanagi K, He J. Lymph node dissection and recurrent laryngeal nerve protection in minimally invasive esophagectomy. Ann N Y Acad Sci 2020;1481:20-9. [PMID: 32671860 DOI: 10.1111/nyas.14427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2006;131:65-72. [PMID: 16399296 DOI: 10.1016/j.jtcvs.2005.08.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
443 Mimura K, Kono K, Maruyama T, Watanabe M, Izawa S, Shiba S, Mizukami Y, Kawaguchi Y, Inoue M, Kono T, Choudhury A, Kiessling R, Fujii H. Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines. Int J Cancer 2011;129:2408-16. [DOI: 10.1002/ijc.25896] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
444 Dresner S, Lamb P, Bennett M, Hayes N, Griffin S. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-9. [DOI: 10.1067/msy.2001.110024] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 5.6] [Reference Citation Analysis]
445 Noshiro H, Nagai E, Shimizu S, Uchiyama A, Kojima M, Tanaka M. Minimally invasive radical esophagectomy for esophageal cancer. Esophagus 2007;4:59-65. [DOI: 10.1007/s10388-007-0109-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
446 Lerut T, Flamen P, Ectors N, Van Cutsem E, Peeters M, Hiele M, De Wever W, Coosemans W, Decker G, De Leyn P. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg. 2000;232:743-752. [PMID: 11088069 DOI: 10.1097/00000658-200012000-00003] [Cited by in Crossref: 196] [Cited by in F6Publishing: 156] [Article Influence: 8.9] [Reference Citation Analysis]
447 Kunisaki C, Hatori S, Imada T, Akiyama H, Ono H, Otsuka Y, Matsuda G, Nomura M, Shimada H. Video-assisted Thoracoscopic Esophagectomy With a Voice-controlled Robot: The AESOP System. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2004;14:323-7. [DOI: 10.1097/01.sle.0000148468.74546.9a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
448 Tamaki Y, Sasaki R, Ejima Y, Ogura M, Negoro Y, Nakajima T, Murakami M, Kaji Y, Sugimura K. Efficacy of intraoperative radiotherapy targeted to the abdominal lymph node area in patients with esophageal carcinoma. J Radiat Res 2012;53:882-91. [PMID: 22872778 DOI: 10.1093/jrr/rrs045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
449 Miyata H, Yano M, Doki Y, Yasuda T, Yoshioka S, Sugita Y, Takiguchi S, Fujiwara Y, Monden M. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes. J Surg Oncol 2006;93:477-84. [DOI: 10.1002/jso.20453] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
450 Morita M, Nakanoko T, Fujinaka Y, Kubo N, Yamashita N, Yoshinaga K, Saeki H, Emi Y, Kakeji Y, Shirabe K, Maehara Y. In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 2011;18:1757-65. [PMID: 21207167 DOI: 10.1245/s10434-010-1502-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
451 Morita M, Egashira A, Yoshida R, Ikeda K, Ohgaki K, Shibahara K, Oki E, Sadanaga N, Kakeji Y, Maehara Y. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol 2008;43:345-51. [DOI: 10.1007/s00535-008-2171-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
452 Pinotti HW, Cecconello I, De Oliveira MA. Transhiatal esophagectomy for esophageal cancer. Semin Surg Oncol 1997;13:253-8. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<253::aid-ssu6>3.0.co;2-4] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
453 Sendler A. [Tumors of the upper gastro-intestinal tract]. Chirurg 2010;81:103-6; 108-10. [PMID: 20076935 DOI: 10.1007/s00104-009-1813-x] [Reference Citation Analysis]
454 Van De Voorde L, Larue RT, Pijls M, Buijsen J, Troost EG, Berbée M, Sosef M, van Elmpt W, Schraepen M, Vanneste B, Oellers M, Lambin P. A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer. Radiotherapy and Oncology 2014;113:166-74. [DOI: 10.1016/j.radonc.2014.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
455 Mafune T, Mikami S, Otsubo T, Saji O, Matsushita T, Enomoto T, Maki F, Tochimoto S. An Investigation of Factors Related to Food Intake Ability and Swallowing Difficulty After Surgery for Thoracic Esophageal Cancer. Dysphagia 2019;34:592-9. [PMID: 31037328 DOI: 10.1007/s00455-019-10010-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Motoyama S, Ishiyama K, Maruyama K, Okuyama M, Sato Y, Hayashi K, Nanjo H, Saito H, Minamiya Y, Ogawa J. Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer. Surgery 2007;141:736-47. [PMID: 17560250 DOI: 10.1016/j.surg.2007.01.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
457 Baba M, Natsugoe S, Shimada M, Nakano S, Noguchi Y, Kawachi K, Kusano C, Aikou T. Does hoarseness of voice from recurrent nerve paralysis after esophagectomy for carcinoma influence patient quality of life? J Am Coll Surg 1999;188:231-6. [PMID: 10065810 DOI: 10.1016/s1072-7515(98)00295-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
458 Zhang J, Peng F, Li N, Liu Y, Xu Y, Zhou L, Wang J, Zhu J, Huang M, Gong Y. Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer. Radiat Oncol. 2012;7:93. [PMID: 22713587 DOI: 10.1186/1748-717x-7-93] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
459 Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, Gu XZ, Zhang DC, Zhang RG, Wang LJ. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg. 2003;75:331-336. [PMID: 12607634 DOI: 10.1016/s0003-4975(02)04401-6] [Cited by in Crossref: 150] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
460 Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. Definitive chemoradiotherapy for T4 and/or M1 Lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915-2921. [PMID: 10561371 DOI: 10.1200/jco.1999.17.9.2915] [Cited by in Crossref: 286] [Cited by in F6Publishing: 111] [Article Influence: 13.0] [Reference Citation Analysis]
461 Delgado Gomis F, Gómez Abril SA, Martínez Abad M, Guallar Rovira JM. Assisted laparoscopic transhiatal esophagectomy for the treatment of esophageal cancer. Clin Transl Oncol 2006;8:185-92. [PMID: 16648118 DOI: 10.1007/s12094-006-0009-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
462 Koide N, Takeuchi D, Suzuki A, Miyagawa S. Mediastinoscopy-assisted esophagectomy for esophageal cancer in patients with serious comorbidities. Surg Today 2012;42:127-34. [DOI: 10.1007/s00595-011-0042-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
463 Wong I, Law S. The management of mid & proximal oesophageal squamous cell carcinoma. Best Pract Res Clin Gastroenterol 2018;36-37:85-90. [PMID: 30551861 DOI: 10.1016/j.bpg.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
464 Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, Fujii H. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008;99:1462-7. [PMID: 18841157 DOI: 10.1038/sj.bjc.6604715] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
465 Tabira Y, Yasunaga M, Tanaka M, Nakano K, Sakaguchi T, Nagamoto N, Ogi S, Kitamura N. Recurrent nerve nodal involvement is associated with cervical nodal metastasis in thoracic esophageal carcinoma. J Am Coll Surg. 2000;191:232-237. [PMID: 10989896 DOI: 10.1016/s1072-7515(00)00348-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
466 Tanaka T, Matono S, Nagano T, Shirouzu K, Fujita H, Yamana H. Esophagectomy with Extended Lymphadenectomy for Submucosal Esophageal Cancer: Long-Term Outcomes and Prognostic Factors. Ann Surg Oncol 2012;19:750-6. [DOI: 10.1245/s10434-011-2023-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
467 Lerut T, Coosemans W, Decker G, De Leyn P, Moons J, Nafteux P, Van Raemdonck D. Extended surgery for cancer of the esophagus and gastroesophageal junction. Journal of Surgical Research 2004;117:58-63. [DOI: 10.1016/j.jss.2003.12.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
468 Okazumi S, Ochiai T, Shimada H, Matsubara H, Nabeya Y, Miyazawa Y, Shiratori T, Aoki T, Sugaya M. Development of less invasive surgical procedures for thoracic esophageal cancer. Dis Esophagus 2004;17:159-63. [PMID: 15230731 DOI: 10.1111/j.1442-2050.2004.00379.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
469 Sohda M, Kuwano H. Current Status and Future Prospects for Esophageal Cancer Treatment. Ann Thorac Cardiovasc Surg. 2017;23:1-11. [PMID: 28003586 DOI: 10.5761/atcs.ra.16-00162] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 13.8] [Reference Citation Analysis]
470 Wang H, Tan L, Feng M, Zhang Y, Wang Q. Comparison of the short-term health-related quality of life in patients with esophageal cancer with different routes of gastric tube reconstruction after minimally invasive esophagectomy. Qual Life Res. 2011;20:179-189. [PMID: 20857337 DOI: 10.1007/s11136-010-9742-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
471 Hulscher JB, van Sandick JW, Tijssen JG, Obertop H, van Lanschot JJ. The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg. 2000;191:143-148. [PMID: 10945357 DOI: 10.1016/s1072-7515(00)00349-5] [Cited by in Crossref: 139] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
472 Koshy M, Esiashvilli N, Landry JC, Thomas CR, Matthews RH. Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist. 2004;9:137-146. [PMID: 15047918 DOI: 10.1634/theoncologist.9-2-137] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
473 Dubecz A, Sepesi B, Salvador R, Polomsky M, Watson TJ, Raymond DP, Jones CE, Litle VR, Wisnivesky JP, Peters JH. Surgical resection for locoregional esophageal cancer is underutilized in the United States. J Am Coll Surg 2010;211:754-61. [PMID: 20980174 DOI: 10.1016/j.jamcollsurg.2010.07.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
474 Yoshida T, Seike J, Miyoshi T, Yamai H, Takechi H, Yuasa Y, Furukita Y, Yamamoto Y, Umemoto A, Tangoku A. Preoperative chemotherapy with weekly docetaxel plus low-dose cisplatin and 5-fluorouracil for stage II/III squamous cell carcinoma of the esophagus. Esophagus 2010;7:95-100. [DOI: 10.1007/s10388-010-0234-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
475 Wang H, Feng M, Tan L, Wang Q. Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Dis Esophagus 2010;23:408-14. [PMID: 19930404 DOI: 10.1111/j.1442-2050.2009.01025.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 22] [Article Influence: 0.3] [Reference Citation Analysis]
476 Wong R, Malthaner R. Esophageal cancer: A systematic review. Current Problems in Cancer 2000;24:293-373. [DOI: 10.1016/s0147-0272(00)80002-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
477 Tong DK, Kwong DL, Law S, Wong KH, Wong J. Cervical nodal metastasis from intrathoracic esophageal squamous cell carcinoma is not necessarily an incurable disease. J Gastrointest Surg 2008;12:1638-45; discussion 1645. [PMID: 18704592 DOI: 10.1007/s11605-008-0654-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
478 Ishibashi-Kanno N, Yamagata K, Fukuzawa S, Uchida F, Yanagawa T, Bukawa H. Incidental cervical lymph node metastasis of papillary thyroid cancer in neck dissection specimens from a tongue squamous cell carcinoma patient: a case report. Oral Maxillofac Surg 2021;25:127-32. [PMID: 32829459 DOI: 10.1007/s10006-020-00894-z] [Reference Citation Analysis]
479 Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Yamada T, Ohue M, Ohigashi H, Ishikawa O, Imaoka S. Excess visceral fat accumulation is a risk factor for postoperative systemic inflammatory response syndrome in patients with esophageal cancer. Esophagus 2008;5:75-80. [DOI: 10.1007/s10388-008-0150-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
480 Balagué C, Vela S. Utilización del ganglio centinela en patología digestiva. Cirugía Española 2007;82:195-203. [DOI: 10.1016/s0009-739x(07)71706-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
481 Frizzell B, Sinha D, Williams T, Reed CE, Sherman CA, Turrisi A. Influence of Celiac Axis Lymph Nodes in the Definitive Treatment of Esophageal Cancer: . American Journal of Clinical Oncology 2003;26:215-20. [DOI: 10.1097/01.coc.0000018295.45046.b7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
482 Ando N, Iizuka T, Kakegawa T, Isono K, Watanabe H, Ide H, Tanaka O, Shinoda M, Takiyama W, Arimori M. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg. 1997;114:205-209. [PMID: 9270637 DOI: 10.1016/s0022-5223(97)70146-6] [Cited by in Crossref: 199] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
483 Sato Y, Kosugi S, Aizawa N, Ishikawa T, Kano Y, Ichikawa H, Hanyu T, Hirashima K, Bamba T, Wakai T. Risk Factors and Clinical Outcomes of Recurrent Laryngeal Nerve Paralysis After Esophagectomy for Thoracic Esophageal Carcinoma. World J Surg 2016;40:129-36. [PMID: 26464155 DOI: 10.1007/s00268-015-3261-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
484 Pye JK, Crumplin MK, Charles J, Kerwat R, Foster ME, Biffin A; Hospital clinicians in Wales. One-year survey of carcinoma of the oesophagus and stomach in Wales. Br J Surg 2001;88:278-85. [PMID: 11167881 DOI: 10.1046/j.1365-2168.2001.01655.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 2.3] [Reference Citation Analysis]
485 Lerut T, Coosemans W, Decker G, De Leyn P, Moons J, Nafteux P, Van Raemdonck D. Surgical techniques. J Surg Oncol. 2005;92:218-229. [PMID: 16299783 DOI: 10.1002/jso.20363] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
486 Darling G. The role of lymphadenectomy in esophageal cancer: Role of Lymphadenectomy in Esophageal Cancer. J Surg Oncol 2009;99:189-93. [DOI: 10.1002/jso.21209] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
487 Na KJ, Kang CH. Current Issues in Minimally Invasive Esophagectomy. Korean J Thorac Cardiovasc Surg 2020;53:152-9. [PMID: 32793445 DOI: 10.5090/kjtcs.2020.53.4.152] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
488 Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Huang CH, Shih LH, Chen SW, Li SH. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy. PLoS One 2018;13:e0198800. [PMID: 29889869 DOI: 10.1371/journal.pone.0198800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
489 Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y. Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011;59:461-6. [PMID: 21751104 DOI: 10.1007/s11748-011-0780-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
490 Altorki NK, Skinner DB. Occult cervical nodal metastasis in esophageal cancer: preliminary results of three-field lymphadenectomy. J Thorac Cardiovasc Surg. 1997;113:540-544. [PMID: 9081100 DOI: 10.1016/s0022-5223(97)70368-4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
491 Nafteux P, Depypere L, Van Veer H, Coosemans W, Lerut T. Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field). Ann Cardiothorac Surg 2017;6:152-8. [PMID: 28447004 DOI: 10.21037/acs.2017.03.04] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
492 Yano M, Motoori M, Tanaka K, Kishi K, Miyashiro I, Shingai T, Gotoh K, Noura S, Takahashi H, Yamada T, Ohue M, Ohigashi H, Ishikawa O. Prevention of gastroduodenal content reflux and delayed gastric emptying after esophagectomy: gastric tube reconstruction with duodenal diversion plus Roux-en-Y anastomosis. Dis Esophagus 2012;25:181-7. [PMID: 21819481 DOI: 10.1111/j.1442-2050.2011.01229.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
493 Park SY, Kim DJ, Yu WS, Jung HS. Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer. Dis Esophagus 2016;29:326-32. [PMID: 25716873 DOI: 10.1111/dote.12335] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
494 Nozoe T, Kakeji Y, Baba H, Maehara Y. Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus. Dis Esophagus. 2005;18:226-229. [PMID: 16128778 DOI: 10.1111/j.1442-2050.2005.00482.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
495 Shang QX, Yang YS, Hu WP, Yuan Y, Ji AF, Chen LQ. Prognostic significance and role of thoracic lymph node metastasis based on Chinese expert consensus in esophageal cancer. Ann Transl Med 2019;7:381. [PMID: 31555695 DOI: 10.21037/atm.2019.07.63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
496 Schurr PG, Yekebas EF, Kaifi JT, Lasch S, Strate T, Kutup A, Cataldegirmen G, Bubenheim M, Pantel K, Izbicki JR. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction. J Surg Oncol 2006;94:307-15. [PMID: 16917878 DOI: 10.1002/jso.20582] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
497 Yang H, Wang J, Huang Q, Zheng Y, Ela Bella A, Wang R, Fu J, Li A, Li X. Intraoperative ultrasonography for the identification of thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer. Dis Esophagus 2016;29:152-8. [PMID: 25604726 DOI: 10.1111/dote.12318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
498 Ellis FH. Standard Resection for Cancer of the Esophagus and Cardia. Surgical Oncology Clinics of North America 1999;8:279-94. [DOI: 10.1016/s1055-3207(18)30213-8] [Cited by in Crossref: 24] [Article Influence: 1.0] [Reference Citation Analysis]
499 Kumai Y, Yoshida N, Kamenosono Y, Matsubara K, Samejima Y, Baba H, Yumoto E. Effects of Chin-Down Maneuver on the Parameters of Swallowing Function After Esophagectomy With 3-Field Lymphadenectomy Examined by Videofluoroscopy. Archives of Physical Medicine and Rehabilitation 2017;98:1174-9. [DOI: 10.1016/j.apmr.2016.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
500 Meszoely IM, Chapman WC, Holzman MD, Leach SD. New trends in gastrointestinal surgical oncology. Cancer Treat Res 1998;98:239-91. [PMID: 10326672 DOI: 10.1007/978-1-4615-4977-2_10] [Reference Citation Analysis]
501 Ninomiya I, Osugi H, Fujimura T, Fushida S, Okamoto K, Maruzen S, Oyama K, Kinoshita J, Tsukada T, Kitagawa H, Takamura H, Nakagawara H, Tajima H, Hayashi H, Makino I, Ohta T. Thoracoscopic esophagectomy with extended lymph node dissection in the left lateral position: technical feasibility and oncologic outcomes. Dis Esophagus 2014;27:159-67. [PMID: 23551804 DOI: 10.1111/dote.12071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
502 Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y, Nishida T, Mano M, Mori M, Doki Y. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer. 2009;115:3324-3334. [PMID: 19452547 DOI: 10.1002/cncr.24390] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 5.7] [Reference Citation Analysis]
503 Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Hara J, Yamamura T, Inoue M. Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma. Mol Clin Oncol 2013;1:773-9. [PMID: 24649245 DOI: 10.3892/mco.2013.128] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
504 Park SY, Kim DJ, Kang DR, Haam SJ. Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer. Dis Esophagus 2017;30:1-9. [PMID: 28881887 DOI: 10.1093/dote/dox094] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
505 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
506 Wang D, Yang J, Zhu J, Li B, Zhai L, Sun M, Gong H, Zhou T, Wei Y, Huang W, Wang Z, Li H, Zhang Z. Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study. Radiat Oncol 2013;8:108. [PMID: 23638721 DOI: 10.1186/1748-717X-8-108] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
507 Leng XF, Daiko H, Han YT, Mao YS. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma. Ann N Y Acad Sci 2020;1482:213-24. [PMID: 33067818 DOI: 10.1111/nyas.14508] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
508 Peracchia A, Rosati R, Fumagalli U, Bona S, Chella B. Thoracoscopic esophagectomy: Are there benefits? Semin Surg Oncol 1997;13:259-62. [DOI: 10.1002/(sici)1098-2388(199707/08)13:4<259::aid-ssu7>3.0.co;2-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
509 Dhar DK, Tachibana M, Kinukawa N, Riruke M, Kohno H, Little AG, Nagasue N. The prognostic significance of lymph node size in patients with squamous esophageal cancer. Annals of Surgical Oncology 2002;9:1010-6. [DOI: 10.1007/bf02574521] [Cited by in Crossref: 33] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
510 Leonard GD, McCaffrey JA, Maher M. Optimal therapy for oesophageal cancer. Cancer Treat Rev. 2003;29:275-282. [PMID: 12927567 DOI: 10.1016/S0305-7372(02)00131-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
511 Taguchi S, Osugi H, Higashino M, Tokuhara T, Takada N, Takemura M, Lee S, Kinoshita H. Comparison of three-field esophagectomy for esophageal cancer incorporating open or thoracoscopic thoracotomy. Surg Endosc. 2003;17:1445-1450. [PMID: 12811660 DOI: 10.1007/s00464-002-9232-9] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
512 Natsugoe S, Mueller J, Kijima F, Aridome K, Shimada M, Shirao K, Kusano C, Baba M, Yoshinaka H, Fukumoto T, Aikou T. Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. Br J Cancer 1997;75:892-7. [PMID: 9062412 DOI: 10.1038/bjc.1997.157] [Cited by in Crossref: 16] [Cited by in F6Publishing: 44] [Article Influence: 0.6] [Reference Citation Analysis]
513 Cariati A, Casano A, Campagna A, Cariati E, Pescio G. Prognostic factors influencing morbidity and mortality in esophageal carcinoma. Rev Hosp Clin 2002;57:201-4. [DOI: 10.1590/s0041-87812002000500002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
514 Tanaka Y, Aoyagi K, Minashi K, Komatsuzaki R, Komatsu M, Chiwaki F, Tamaoki M, Nishimura T, Takahashi N, Oda I, Tachimori Y, Arao T, Nishio K, Kitano S, Narumi K, Aoki K, Fujii S, Ochiai A, Yoshida T, Muto M, Yamada Y, Sasaki H. Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy. PLoS One 2015;10:e0143804. [PMID: 26625258 DOI: 10.1371/journal.pone.0143804] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
515 Nusrath S, Saxena AR, Raju KVVN, Patnaik S, Subramanyeshwar Rao T, Bollineni N. The Value of Lymphadenectomy Post-Neoadjuvant Therapy in Carcinoma Esophagus: a Review. Indian J Surg Oncol 2020;11:538-48. [PMID: 33013140 DOI: 10.1007/s13193-020-01156-w] [Reference Citation Analysis]
516 Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H. A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg. 2003;90:108-113. [PMID: 12520585 DOI: 10.1002/bjs.4022] [Cited by in Crossref: 164] [Cited by in F6Publishing: 137] [Article Influence: 8.6] [Reference Citation Analysis]
517 Noshiro H, Kai K, Yoda Y, Kono H, Uchiyama A. Palsy of the recurrent laryngeal nerves in association with an ultrasonic activated device during thoracoscopic esophagectomy with three-field lymphadenectomy. Esophagus 2016;13:351-60. [DOI: 10.1007/s10388-016-0543-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
518 Doki Y, Ishikawa O, Takachi K, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Yamada T, Noura S, Eguchi H. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg. 2005;29:700-707. [PMID: 16078126 DOI: 10.1007/s00268-005-7596-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
519 Tachimori Y, Ozawa S, Numasaki H, Matsubara H, Shinoda M, Toh Y, Udagawa H, Fujishiro M, Oyama T, Uno T; Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1-7. [PMID: 26752982 DOI: 10.1007/s10388-015-0515-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 8.7] [Reference Citation Analysis]
520 Takeuchi H, Kawakubo H, Nakamura R, Fukuda K, Takahashi T, Wada N, Kitagawa Y. Clinical Significance of Sentinel Node Positivity in Patients with Superficial Esophageal Cancer. World J Surg. 2015;39:2941-2947. [PMID: 26296842 DOI: 10.1007/s00268-015-3217-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
521 Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 1999;72:88-93. [DOI: 10.1002/(sici)1096-9098(199910)72:2<88::aid-jso9>3.0.co;2-v] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
522 Li BS, Zhou T, Wang ZT, Li HS, Sun HF, Zhang ZC, Lin HQ, Wei YM, Gong HY, Huang W, Yi Y, Wang LY. Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma. Radiother Oncol 2009;93:458-61. [PMID: 19733411 DOI: 10.1016/j.radonc.2009.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
523 Gockel I, Sgourakis G, Lyros O, Hansen T, Lang H. Dissection of lymph node metastases in esophageal cancer. Expert Rev Anticancer Ther 2011;11:571-8. [PMID: 21504324 DOI: 10.1586/era.10.157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
524 Yano M, Miyata H, Sugimura K, Motoori M, Omori T, Fujiwara Y, Miyoshi N, Yasui M, Ohue M, Akita H, Tomokuni A, Takahashi H, Kobayashi S, Sakon M. 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the prediction of survival in patients with advanced esophageal cancer who have undergone neoadjuvant chemotherapy. Mol Clin Oncol 2018;8:434-40. [PMID: 29456850 DOI: 10.3892/mco.2018.1546] [Reference Citation Analysis]
525 Nakagawa S, Nishimaki T, Kosugi S, Ohashi M, Kanda T, Hatakeyama K. Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagus. Diseases of the Esophagus 2003;16:4-8. [DOI: 10.1046/j.1442-2050.2003.00286.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
526 Du D, Song T, Liang X, Fang M, Wu S. Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature. Dis Esophagus 2017;30:1-9. [PMID: 26918886 DOI: 10.1111/dote.12471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
527 Saha S, Dehn TC. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. Dis Esophagus 2001;14:32-6. [PMID: 11422303 DOI: 10.1111/j.1442-2050.2001.00148.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
528 Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, Shinno N, Yasui M, Takahashi H, Wada H, Ohue M, Yano M. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery 2019;166:1033-40. [PMID: 31493901 DOI: 10.1016/j.surg.2019.07.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
529 Kranzfelder M, Büchler P, Friess H. Surgery within multimodal therapy concepts for esophageal squamous cell carcinoma (ESCC): the MRI approach and review of the literature. Adv Med Sci. 2009;54:158-169. [PMID: 20022858 DOI: 10.2478/v10039-009-0044-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
530 Ninomiya I, Okamoto K, Fujimura T, Fushida S, Osugi H, Ohta T. Oncologic Outcomes of Thoracoscopic Esophagectomy with Extended Lymph Node Dissection: 10-year Experience from a Single Center. World J Surg 2014;38:120-30. [DOI: 10.1007/s00268-013-2238-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
531 Lin J, Iannettoni MD. Transhiatal Esophagectomy. Surgical Clinics of North America 2005;85:593-610. [DOI: 10.1016/j.suc.2005.01.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
532 Matsuda S, Kawakubo H, Irino T, Kitagawa Y. Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer. Jpn J Clin Oncol 2021:hyab192. [PMID: 34891170 DOI: 10.1093/jjco/hyab192] [Reference Citation Analysis]
533 Komori T, Doki Y, Kabuto T, Ishikawa O, Hiratsuka M, Sasaki Y, Ohigashi H, Murata K, Yamada T, Miyashiro I, Mano M, Ishiguro S, Imaoka S. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers. J Surg Oncol 2003;82:19-27. [DOI: 10.1002/jso.10184] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
534 Mora A, Nakajima Y, Okada T, Tokairin Y, Kawada K, Kawano T. Comparative Study of Predictive Mortality Scores in Esophagectomy with Three-Field Lymph Node Dissection in Patients with Esophageal Cancer. Dig Surg 2019;36:67-75. [PMID: 29393197 DOI: 10.1159/000486551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
535 Wong IYH, Lam KO, Chan W, Wong C, So TH, Chan KK, Choi CW, Law TT, Chiu K, Chan FSY, Kwong DLW, Law S. Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma. J Gastrointest Surg 2020;24:1937-47. [DOI: 10.1007/s11605-020-04704-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
536 Igaki H, Kato H, Tachimori Y, Nakanishi Y. Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus. J Surg Oncol 2000;75:37-41. [DOI: 10.1002/1096-9098(200009)75:1<37::aid-jso7>3.0.co;2-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
537 Wada T, Takeuchi H, Kawakubo H, Nakamura R, Oyama T, Takahashi T, Wada N, Saikawa Y, Omori T, Jinzaki M, Kuribayashi S, Kitagawa Y. Clinical utility of preoperative evaluation of bronchial arteries by three-dimensional computed tomographic angiography for esophageal cancer surgery. Dis Esophagus 2013;26:616-22. [PMID: 23237474 DOI: 10.1111/dote.12012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
538 Hashiguchi T, Nasu M, Hashimoto T, Kuniyasu T, Inoue H, Sakai N, Ouchi K, Amano T, Isayama F, Tomita N, Iwanuma Y, Tsurumaru M, Kajiyama Y. Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer. Mol Clin Oncol 2014;2:719-24. [PMID: 25054036 DOI: 10.3892/mco.2014.320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
539 Kogo M, Suzuki A, Kaneko K, Yoneyama K, Imawari M, Kiuchi Y. Scoring system for predicting response to chemoradiotherapy, including 5-Fluorouracil and platinum, for patients with esophageal cancer. Dig Dis Sci 2008;53:2415-21. [PMID: 18256935 DOI: 10.1007/s10620-007-0149-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
540 Nagamatsu Y, Shima I, Yamana H, Fujita H, Shirouzu K, Ishitake T. Preoperative evaluation of cardiopulmonary reserve with the use of expired gas analysis during exercise testing in patients with squamous cell carcinoma of the thoracic esophagus. The Journal of Thoracic and Cardiovascular Surgery 2001;121:1064-8. [DOI: 10.1067/mtc.2001.113596] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 4.0] [Reference Citation Analysis]
541 Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. European Journal of Surgical Oncology (EJSO) 2006;32:749-55. [DOI: 10.1016/j.ejso.2006.03.048] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
542 Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338-344. [PMID: 11224620 DOI: 10.1097/00000658-200103000-00006] [Cited by in Crossref: 261] [Cited by in F6Publishing: 228] [Article Influence: 12.4] [Reference Citation Analysis]
543 Shiozaki H, Yano M, Tsujinaka T, Inoue M, Tamura S, Doki Y, Yasuda T, Fujiwara Y, Monden M. Lymph node metastasis along the recurrent nerve chain is an indication for cervical lymph node dissection in thoracic esophageal cancer. Dis Esophagus. 2001;14:191-196. [PMID: 11869318 DOI: 10.1046/j.1442-2050.2001.00206.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 3.3] [Reference Citation Analysis]
544 Shindo K, Nagai E, Nabae T, Eguchi T, Moriyama T, Ohuchida K, Manabe T, Ohtsuka T, Oda Y, Hashizume M, Nakamura M. Successful video-assisted thoracoscopic surgery in prone position in patients with esophageal cancer and aberrant right subclavian artery: report of three cases. Surg Case Rep 2017;3:86. [PMID: 28755160 DOI: 10.1186/s40792-017-0360-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
545 Nishimaki T, Suzuki T, Nakagawa S, Watanabe K, Aizawa K, Hatakeyama K. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma. J Surg Oncol 1997;64:130-4. [DOI: 10.1002/(sici)1096-9098(199702)64:2<130::aid-jso8>3.0.co;2-c] [Cited by in Crossref: 45] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
546 Komine O, Tanaka Y, Kawashima Y, Sakamoto H, Watanabe M, Suzuki H, Tokunaga A, Uchida E. Short-term postoperative superiority and 5-year follow-up outcomes of video-assisted thoracoscopic esophagectomy for treatment of esophageal carcinoma: a historical comparison with conventional open esophagectomy under a single experienced surgeon. Esophagus 2014;11:54-63. [DOI: 10.1007/s10388-013-0388-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
547 Mimori K, Mori M, Inoue H, Ueo H, Mafune K, Akiyoshi T, Sugimachi K. Elongation factor 1 gamma mRNA expression in oesophageal carcinoma. Gut 1996;38:66-70. [PMID: 8566862 DOI: 10.1136/gut.38.1.66] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 1.3] [Reference Citation Analysis]
548 Adham M, Baulieux J, Mornex F, de la Roche de Bransat E, Ducerf C, Souquet JC, Gerard JP. Combined chemotherapy and radiotherapy followed by surgery in the treatment of patients with squamous cell carcinoma of the esophagus: The Croix Rousse experiences. Cancer 2000;89:946-54. [DOI: 10.1002/1097-0142(20000901)89:5<946::aid-cncr2>3.0.co;2-3] [Cited by in Crossref: 32] [Article Influence: 1.5] [Reference Citation Analysis]
549 Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005;103:1347-1355. [PMID: 15719440 DOI: 10.1002/cncr.20916] [Cited by in Crossref: 279] [Cited by in F6Publishing: 282] [Article Influence: 16.4] [Reference Citation Analysis]
550 Motoori M, Yano M, Tomita Y, Takahashi H, Tanaka K, Sugimura K, Kishi K, Fujiwara Y, Miyoshi N, Akita H, Goto K, Marubashi S, Noura S, Ohue M, Ishikawa O, Sakon M. Tissue factor predicts response to chemotherapy in esophageal cancer. Journal of Surgical Research 2014;191:99-105. [DOI: 10.1016/j.jss.2014.03.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
551 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
552 Li H, Zhang Y, Cai H, Xiang J. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Eur Surg Res. 2007;39:1-6. [PMID: 17106199 DOI: 10.1159/000096925] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
553 Kitagawa Y, Saha S, Kubo A, Kitajima M. Sentinel node for gastrointestinal malignancies. Surg Oncol Clin N Am 2007;16:71-80. [PMID: 17336237 DOI: 10.1016/j.soc.2006.10.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
554 Balandraud P, Moutardier V, Giovannini M, Giovannini M, Lelong B, Guiramand J, Magnin V, Houvenaeghel G, Delpero J. Locally advanced adenocarcinomas of the gastric cardia: results of pre-operative chemoradiotherapy. Gastroentérologie Clinique et Biologique 2004;28:651-7. [DOI: 10.1016/s0399-8320(04)95043-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
555 Kim HK, Kim S, Park JJ, Jeong JM, Mok YJ, Choi YH. Sentinel node identification using technetium-99m neomannosyl human serum albumin in esophageal cancer. Ann Thorac Surg 2011;91:1517-22. [PMID: 21377648 DOI: 10.1016/j.athoracsur.2011.01.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
556 Takeuchi H, Fujii H, Ando N, Ozawa S, Saikawa Y, Suda K, Oyama T, Mukai M, Nakahara T, Kubo A, Kitajima M, Kitagawa Y. Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 2009;249:757-63. [PMID: 19387329 DOI: 10.1097/SLA.0b013e3181a38e89] [Cited by in Crossref: 77] [Cited by in F6Publishing: 26] [Article Influence: 5.9] [Reference Citation Analysis]
557 Kataoka K, Nakamura K, Mizusawa J, Fukuda H, Igaki H, Ozawa S, Hayashi K, Kato K, Kitagawa Y, Ando N. Variations in survival and perioperative complications between hospitals based on data from two phase III clinical trials for oesophageal cancer. Br J Surg 2015;102:1088-96. [PMID: 26095389 DOI: 10.1002/bjs.9839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
558 Hsu WH, Hsu PK, Hsieh CC, Huang CS, Wu YC. The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer. J Gastrointest Surg. 2009;13:1913-20. [PMID: 19672664 DOI: 10.1007/s11605-009-0982-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
559 Vrieze O, Haustermans K, De Wever W, Lerut T, Van Cutsem E, Ectors N, Hiele M, Flamen P. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol. 2004;73:269-275. [PMID: 15588870 DOI: 10.1016/j.radonc.2004.10.001] [Cited by in Crossref: 101] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
560 Vallbohmer D, Oh DS, Peters JH. The role of lymphadenectomy in the surgical treatment of esophageal and gastric cancer. Curr Probl Surg 2012;49:471-515. [PMID: 22793506 DOI: 10.1067/j.cpsurg.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
561 Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y, Fujii H. Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci. 2009;100:1502-1509. [PMID: 19459850 DOI: 10.1111/j.1349-7006.2009.01200.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 7.8] [Reference Citation Analysis]
562 Sato F, Shimada Y, Li Z, Kano M, Watanabe G, Maeda M, Kawabe A, Kaganoi J, Itami A, Nagatani S, Imamura M. Paratracheal lymph node metastasis is associated with cervical lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma. Ann Surg Oncol 2002;9:65-70. [DOI: 10.1245/aso.2002.9.1.65] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
563 Yamashita H, Nakagawa K, Yamada K, Kaminishi M, Mafune K, Ohtomo K. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma. Dis Esophagus 2008;21:430-6. [PMID: 19125797 DOI: 10.1111/j.1442-2050.2007.00793.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
564 Tanaka E, Okabe H, Kinjo Y, Tsunoda S, Obama K, Hisamori S, Sakai Y. Advantages of the prone position for minimally invasive esophagectomy in comparison to the left decubitus position: better oxygenation after minimally invasive esophagectomy. Surg Today 2015;45:819-25. [PMID: 25387656 DOI: 10.1007/s00595-014-1061-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
565 Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 2006;106:552-8. [DOI: 10.1002/cncr.21601] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 3.2] [Reference Citation Analysis]
566 Schneider PM, Vallböhmer D, Brabender J, Hölscher AH. [Preoperative evaluation of prognostic factors in esophageal squamous cell cancer]. Chirurg 2005;76:1011-7. [PMID: 16247636 DOI: 10.1007/s00104-005-1109-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
567 Ishikawa N, Kawaguchi M, Inaki N, Moriyama H, Shimada M, Watanabe G. Robot-Assisted Thoracoscopic Hybrid Esophagectomy in the Semi-Prone Position Under Pneumothorax: Thoughts and Progress. Artificial Organs 2013;37:576-80. [DOI: 10.1111/aor.12018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
568 Shimada H, Nabeya Y, Matsubara H, Okazumi S, Shiratori T, Shimizu T, Aoki T, Shuto K, Akutsu Y, Ochiai T. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. Am J Surg. 2006;191:250-254. [PMID: 16442955 DOI: 10.1016/j.amjsurg.2005.07.035] [Cited by in Crossref: 96] [Cited by in F6Publishing: 94] [Article Influence: 6.0] [Reference Citation Analysis]
569 Korst RJ. Surgical resection for esophageal carcinoma: Speaking the language. World J Gastroenterol 2005; 11(15): 2211-2212 [PMID: 15818727 DOI: 10.3748/wjg.v11.i15.2211] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
570 Schrager JJ, Tarpley JL, Smalley WE, Austin MT, Pearson AS. Endoscopic ultrasound: impact on survival in patients with esophageal cancer. Am J Surg 2005;190:682-6. [PMID: 16226939 DOI: 10.1016/j.amjsurg.2005.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]